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Snake and scorpion venoms contain many toxins that have important application as 
therapeutic agents and also as research tools. As a first part of this study, a snake venom 
neurotoxin (NTX) database was constructed using bioinformatics. Snake NTXs are a 
large family of active peptides with considerable sequence homology, but with different 
biological properties. Sequence, functional and structural information on snake venom 
neurotoxins (svNTXs) are scattered across multiple sources such as journals, books and 
public databases, with very limited functional annotation. Through this study, an on-line 
database of NTX proteins has been made available at http://sdmc.12r.a-
star.edu.sg/Templar/DB/snake_neurotoxin. This database can also be found under Swiss-
Prot Toxin Annotation Project website http://www.expasy.org/sprot. At present, 272 
NTXs sequences are available in the database and each sequence contains fully annotated 
function and literature references. An annotation tool was also incorporated to aid 
functional prediction of newly identified NTXs as an additional resource for 
toxinologists. In addition, a classification system based on structure-function and 
phylogeny relationship derived from 272 NTXs has been proposed and discussed in detail 
in the thesis. 
 
In Traditional Chinese Medicine, the scorpion venom has been used in the treatment of 
neuromuscular diseases such as paralysis, epilepsy, apoplexy, hemiplegic and facial 
paralysis. The screening of these peptides have been carried out using proteomics. Hence, 
as a second part of this study, a preliminary screening for therapeutic peptides has been 
carries out using the gene chip microarray and real-time PCR on the Chinese scorpion 
venom. Several interesting peptides have been found to induce changes in expression of 
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1.1 General introduction 
 
The animal kingdom contains many venomous species, including the coelenterates, 
flatworms, annelids, echinoderms, mollusks, arthropods and chordates. These venomous 
animals produce a variety of toxins to defend themselves from predators, to subdue their prey 
and for digestion. Therefore, animal toxins have immobilizing effects and killing functions 
towards a wide variety of creatures.  
 
Snake venoms have attracted much medical attention since ancient civilizations and had been 
used in medical treatment for thousands of years. In the 12th century, doctors used snake 
venom to treat leprosy. Snakes belong to the order Squamata and suborder Serpentes 
(Ophidia) of the class Reptilia (Kochva, 1987). They appeared in the Lower Cretaceous 
Period about 130 million years ago, and have been considered to have evolved from lizards, 
Varanidae, probably 30 million years ago (Clifford, 1955). There are about 3200 species of 
snakes found worldwide, and 1300 of which are venomous (Hider, 1991). Venomous snakes 
belong to the infraorder Caenophidia under Ophidia. They are more advanced and 
widespread throughout the world (Phelps, 1989). Venomous snakes usually are defined as 
those possessing a pair of venom glands and specialized fangs connected to venom glands by 
ducts. The venom apparatus enables them to inflict serious bites in their victims. The venom 
apparatus of a snake typically consists of a venom gland, venom duct and one or more fangs 
located on each side of the head (Figure 1.1A). Venom is produced in paired modified 
salivary glands which in most venomous snakes are located superficially beneath the scales in 
the posterior part of the head and eyes. The gland is linked to the fang by a duct. Contraction 
of muscles around the gland compresses the gland, forcing the flow of venom along the duct 




 Generally, four families of venomous snakes are known: Elapidae (cobra, mamba); 
Hydrophiidae (sea snakes); Viperidae (true vipers and pit vipers and rattlesnakes) and 
Colubridae (boomslang and mangrove; Fenton, 2002).  
 
The elapids are a large group of venomous snakes, which are distributed over Africa, Asia, 
the Southern parts of North America, Central and South America and Australia (Phelps, 
1989).  There are about two hundred and twenty species of elapid snakes which are 
represented by sixty-two genera. Generally, the elapids possess fixed front fangs that are 
situated in the front of the upper jaw (Figure 1.1B). Most elapids are either terrestrial or 
aquatic; only two genera are arboreal, the mambas and the tree cobras, Pseudohaje (Phelps, 
1989).  
   
Hydrophids or sea snakes are widely distributed throughout the equatorial and tropical 
regions of the Indian and Pacific oceans, from the coast of Africa and America. They are 
closely related to the elapids, having a similar venom and fang apparatus. Medically 
important genera include Enhydrina, Hydrophis, Pelamis and Laticauda.  
 
Viperids are amongst the best known and probably the most medically important venomous 
snakes. They are divided into two subfamilies, the viperin and crotalid. The crotalid 
encompasses all the pit vipers and are so called because they possess heat sensitive pits 
situated on each side of the head between the nostril and the eye. The heat-sensing pits enable 
the animals to detect a temperature change of 1 – 2°C above ambient from a distance of 1 – 2 
feet. This facility is used for hunting warm-blooded preys at night. All members of the 
viperid family have a set of very well-developed anteriorly-placed proteroglyphous fang 
structure. The fangs are on a modified maxilla which is capable of considerable rotation thus 
allowing the fangs to be folded against the roof of the mouth when not in use. This has 
enabled the development of larger fangs than in other venomous snakes of equivalent size. 
The crotalids are typically New World snakes found in America and parts of Southeast Asia, 
but are absent from Australia and Europe. Medically-important genera include Crotalus, 
Trimeresurus, Agkistrodon, and Sistrurus. The subfamily of crotalids, viperin is found in 
Africa, Asia and Europe. 
Introduction 
 3
The colubrid family is the largest single snake family with over 2500 species. It is found 
throughout the world on all continents except Antarctica (where no snakes exist). There are 
some species within this family which have developed toxic salivary secretions which may 
enter a snake bite wound during the envenomation. However, current evidence suggests that 
the majority of colubrids do not produce toxic secretions. All colubrids are back-fanged 
(Minton, 1990). The position of the fangs limits fang length and makes it less easy for the 
snake to bite its victim. Nevertheless, several colubrids have extremely potent venoms and 
can cause serious envenomation and death in Man. The best known and most important of 
these are some South African colubrids. The distribution of venomous snakes in the world 














Figure 1.1: Venom apparatus of Naja sputatrix, a Malayan spitting cobra. A) Illustration 
showing fangs, venom duct and the main venom gland. B) Scanning electron micrograph of 























Table 1.1: Systematic classification of different species of snakes around the world 
(Harris et al. 1991).  
 
1.2 Snake venom components 
 
Snake venoms are a complex mixture of various components with wide-ranging activities. 
The composition is variable within a single subspecies or even an individual snake, 
depending on age and season. The function of the venom is to subdue the prey. It also serves 
as a defensive adaptation and to facilitate in the digestion of they prey (Zeller, 1977). Snake 
venoms are usually colorless to dark amber viscous fluids with a viscosity of 1.5 to 2.5 and 
specific gravity of 1.03 to 1.12 (Devi, 1968). Most of the snake venoms consist of a complex 
mixture of proteins and non-protein components. The non-polypeptide components are the 
least biologically active venom fraction. They are mainly amines, carbohydrates, nucleosides, 
lipids, small peptides and metal ions (Devi, 1968). The lipids, carbohydrates and nucleosides 
are present in low amount (1 - 2% of dry weight).  
 
Enzymatic and non-enzymatic components constitute the polypeptide protein and together 
they are made up over 90% of dry weight of snake venom (Hider et al., 1991). Most enzymes 
and toxins are very stable. It was found that dried snake venom retains lethality and some 
enzymatic activities even after storage for 25 – 50 years (Minton, 1990). The enzymatic 
components range between 13 – 150kD and more than twenty enzymes have been detected in 
snake venoms. Twelve of them are found in all venoms, although their levels differ markedly 
(Table 1.2).  
Family Species Distribution Special characterictics
Elapidae Kraits, Cobra, Mambas, Coral snakes America, Asia, Africa, and Small head, short and fixed fangs
Australia
Viperidae Viper snakes Europe, Africa, Asia and America Large, flattened triangular head;
large grooved fangs on  the maxillary bone
Colubridae Tree snakes In all parts of the world except Australia Similar to Viperidae, but they possess  
heat-snesitive pits on head




Many of these enzymes are hydrolases such as exo- and endopeptidases and proteinases that 
play a role in digestion. Others include neurotoxic phospholipase A2 (PLA2) that blocks 
neuromuscular transmission, and hyaluronidase which facilitates the distribution of other 
venom components throughout the prey (Harris, 1991). In addition, proteases that are 
involved in blood coagulation can also be found in snake venom (Matsui et al., 2000). 
 
The non-enzymatic polypeptides (5 – 10kD) found in snake venoms include cardiotoxins 
(CTX, also called cytotoxins), neurotoxins, proteinase inhibitors, dendrotoxins, myotoxins 














The first amino acid sequence of a neurotoxin, Tx α from Naja nigricollis was reported in 1967 
(Eaker and Porath, 1967). Since then, a large number of neurotoxins have been isolated and 
characterized. Reports on the amino acid sequences of a number of homologous neurotoxins 
from snakes such as cobras, kraits, mambas and sea snakes have been added to this growing 
list of neurotoxins. At present, more than 100 neurotoxin amino acid sequences are known and 




All snakes L- Amino acid oxidase, phosphodiesterase, 5'-nucleotidase, phosphomonoesterase, deoxyribonuclease, 
hyaluronidase, NAD-nucleosidase, peptidase and phospholipase A2,ribonuclease, adenosine triphosphatase,
Crotalids and viperids Endopeptidase, arginine ester hydrolase, kininogenase, thrombin-like enzyme, factor X- activator, prothrombin activator
Elapids Acetylcholinesterase, phospholipase B amnd glycerophosphatase
Some snakes Glutamic-pyruvic transaminase, catalase, amylase and B-glucosaminidase
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Neurotoxins are capable of blocking nerve transmission by binding specifically to nicotinic 
acetylcholine receptor (nAChR) located on the postsynaptic membranes of skeletal muscles 
and neurons resulting in prevention of neuromuscular transmission leading to death by 




Neurotransmission takes place between neuron and neuron as well as between nerve and 
muscle cells. When a normal nerve impulse (depolarization wave) passes through the axon and 
reaches the end of that axon, the calcium ion concentration in axon is increased and the 
neurotransmitter, acetylcholine, is released from the vesicle at the end of the nerve. This 
neurotransmitter moves across the synaptic crevice and reaches its receptor (acetylcholine 
receptor, AChR) in the next neuron (as in nerve-nerve synapse) or in muscle (as in nerve-
muscle synapse; Figure 1.2). The neuronal AChR is composed of five subunits, α2β3. When 
two molecules of acetylcholine attach to the two α-subunits, the AChR changes its 
configuration and becomes an open ion channel, permitting certain ions to pass through so that 
the cell’s plasma membrane gets depolarized relatively rapidly, yet transiently, from its resting 
value (-50 mV to –100 mV) to a potential more positive than 0 mV. The depolarization wave 
reaches the next neuron and can be transmitted to muscle similarly. The depolarization wave 
transmitted to muscle is further propagated through the muscle plasma membranes, T-tubules 
and sarcoplasmic reticulum (SR). The SR has a very high concentration of calcium ions. When 
the depolarization wave reaches the SR, the calcium ions begin to leak out of SR and into the 
myoplasm, causing the myofilaments to contract. As soon as the muscle is relaxed, the calcium 




















Figure 1.2: Mechanism of acetylcholine transmission at neuromuscular junction. 
Acetylcholine is formed by choline and acetylcholine-CoA by choline acetyltransferase in the 
cytosol and stored in synaptic vesicle. The arrival of action potential at the terminus of 
presynaptic membrane causes release of acetylcholine which leads to resulting influx of Na+ 
into the postsynaptic membrane. After release from synaptic cleft, acetylcholine will be 
degraded by acetylcholinesterase into choline and acetate. Image obtained from Changeux 
(1993). 
 
1.3.2 Neurotoxins and envenomation 
 
Snake envenomation is a major clinical problem worldwide, particularly in parts of the Asian 
region where the annual mortality is estimated to be 100, 000 (Ingels, 2001). Neurotoxins have 
been found most frequently in venoms of snakes of the family Elapidae and their closest 
relatives, Hydrophiidae. Only a few neurotoxins have been identified in venoms of vipers 
(Viperidae). The clinical manifestations of snakebite depend on two important factors: the 
intrinsic toxicity of the venom on man and the amount injected. A general observation of 
neurotoxic snake envenomation is the development of cranial nerve palsies which is 
characterized by ptosis, blurred vision, difficulty in swallowing, slurred speech, weakness of 
facial muscle and occasionally loss of the sense of taste and smell (Figure 1.3). This syndrome 
is often accompanied by drowsiness, sometimes with mental confusion and euphoria. The 




Both groups of pre- and postsynaptic apparently involved in most of the clinical 
manifestations. Evidence suggests that presynaptic neurotoxins are associated with delayed 
onset, prolonged symptoms and poor response to antivenoms, whereas the postsynaptic toxins 
account for the early paralytic symptoms such as ptosis (Minton, 1990). A brief summary of 
neurotoxin envenoming in Elapidae, Hydrophiidae and Viperinae families of snake is 









Table 1.3: Envenomation effects of neurotoxins across three different species. Data 
adapted from Minton, (1990). √ and x indicate the presence and absence of the observed 









Figure 1.3: Clinical manisfestations of a snake bite. A. Ptosis and moderate facial weakness 
following the bite of an Australian tiger snake.  B. Muscular weakness with the inability to 
raise the head seen following a cobra bite in Malaysia. This is typical of a “broken-neck” 
syndrome reported after bites of snake with neurotoxic venoms (Minton, 1990).  
 
 
 Elapidae Hydrophiidae Viperinae 
Cranial nerve palsies √  √  √  
Local pain and swelling √  √  √  
Local necrosis √  x √  
Respiratory paralysis √  √  √  
Rhabdomyonecrosis √  √  √  
Renal failure √  √  √  





1.4 Classification of neurotoxins 
 
Snake neurotoxins can be divided into two groups: presynaptic or postsynaptic neurotoxins 
depending on their mode of action. Presynaptic neurotoxins are either phospholipase A2 
enzymes or contain these enzymes as an integral part of the neurotoxin complex and, 
essentially, mediate their neurotoxicity by inhibiting the release of acetylcholine (Yang, 1994).  
 
The postsynaptic neurotoxins bind to postsynaptic nAChRs at the skeletal muscle 
neuromuscular junction to produce blockade of neuromuscular transmission (Lee, 1972). These 
neurotoxins are also referred to as curaremimetic or α-neurotoxins.  
 
1.4.1 Presynaptic neurotoxins 
 
A toxin is considered presynaptically active if it can affect transmitter synthesis, storage, 
release or turnover, no matter whether the toxin concerned is active in other regards or not 
(Harris, 1991). Two kinds of snake venom presynaptic toxins have been recognized so far: 1) 
β-neurotoxins characterized by a phospholipase A2 (PLA2) activity; 2) neurotoxins devoid of 
enzymatic activity of PLA2, acting either by blocking a voltage-sensitive K+-channel, like 
dendrotoxin (Hawgood and Bon, 1991) or by inhibiting the activity of acetylcholinesterase, 
with similar overall effect to the increase of acetylcholine, like acetylcholinesterase inhibitor 




β-neurotoxins are defined as presynaptically active PLA2 toxins which have a dominant 
inhibitory action on the indirectly elicited twitch in in vitro neuromuscular preparations by 
blocking the acetylcholine release (Fletcher and Rosenberg, 1997). The first β-neurotoxins 
characterized is β-bungarotoxin from Bungarus multicinctus (Chang and Lee, 1963). It is now 
clear that many of the snake venom PLA2 from kraits, elapids, crotalids and virepids are 
presynaptically active (Harris, 1991; Hawgood and Bon, 1991).  
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β-neurotoxins may be single chain polypeptides as in notexin (Halpert and Eaker, 1975), multi-
subunit complexes as in crotoxin (A and B chains; Bouchier et al., 1991) and taipoxin (α, β, γ 
chains; Fohlman et al., 1977), or covalently linked assemblies of two or more subunits as in β-
bungarotoxin (Kondo et al., 1978), and textilotoxin consisting of five subunits (A, B, C and 
two D) with only two identical D subunits covalently linked (Tyler et al., 1987). The lethal 
activity of these proteins largely depends on the complexity of their quarternary structures. 
Multimeric β-neurotoxins have been found to be more potent than monomeric toxins. LD50 
(median lethal dose, µg/ kg mouse) varies, from 50 in case of crotoxin, to 15 for β-
bungarotoxin, 2 for taipoxin and 1 for textilotoxin (Lee and Ho, 1982). In all cases, systematic 
intoxication resulted in respiratory paralysis due to cessation of neurotransmission.  
 
β-bungarotoxin being the first presynaptic neurotoxins to be discovered, is very well studied. 
The toxin is made up of two structurally different subunits linked by a disulfide bridge.  Chain 
A (120 amino acid, MW 13.5 kDa) is a PLA2 and chain B resembles proteinase inhibitors and 
dendrotoxin or toxin I from Dendroaspis venoms. The overall fold in β-bungarotoxin is 
strikingly similar to that of the mammalian class I and class II PLA2 enzymes (Kondo et al., 
1982a, b; Kwong et al., 1995). It was postulated that neuronal acceptors of β-neurotoxins 
existed to direct β-neurotoxins almost exclusively towards the neuronal presynaptic plasma 
membrane.  For example, the acceptors for β-bungarotoxin have been found to consist of 
subunits of voltage-sensitive K+ channels (Benishin, 1990). Chain B of β-bungarotoxin, which 
is structurally similar to dendrotoxin, has been found to be responsible for the interaction 
between toxin and its receptor. This result has been further supported by the observation that β-
bungarotoxin can bind at high-affinity with dendrotoxin receptors. Crotoxin, another multi-
subunit β-neurotoxin, has been found to dissociate on reaching its target site, with the non-
enzymatic subunit chaperoning the PLA2 subunit to high-affinity sites in synaptic membranes 
(Bon et al., 1979). 
 
It seems that all β-neurotoxins selectively decrease the fast K+ current flowing out of the nerve 
terminal and hence, they interact with a voltage-sensitive K+ channel, as in the case of β-
bungarotoxin and dendrotoxin. On the other hand, the absence of competition for their high-
affinity binding on synaptosomal membranes between the various β-neurotoxins indicates that 
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the various β-neurotoxins bind to different acceptor proteins. Hence, one can conclude that 
various β-neurotoxins recognize various subtypes of voltage-sensitive K+ channel. 
 
Presynaptic neurotoxins induce blockage of neurotransmitter release in three phases. The initial 
transient inhibitory phase is followed by a facilitatory second phase and a late inhibitory phase 
which is irreversible. In the first two phases, the enzymatic activity of the toxins apparently 
plays no role, but is undoubtly needed in the third phase, in which a substantial decrease in the 
number of the synaptic vesicles leads to final disappearance of the amount of neurotransmitter 
stock in the nerve endings. A synaptic vesicle cycle is found to consist of 9 steps: docking, 
priming, fusion/exocytosis, endocytosis, translocation, endosome fusion, budding, 
neurotransmitter uptake and translocation back to the active zone at the plasma membrane in 
the synaptic cleft (Sudhof, 1995; Van der Kloot and Kloot, 1994). The disappearance of the 
neurotransmitter may be due to the interference of the last five steps of the synaptic vesicle 
recycling. 
 
Clues related to the neurotoxicity of β-neurotoxins have been available, even though further 
studies are still required. First, the enzymatic activity is known to be required for the 
expression of neurotoxicity, as shown in the third phase of β-neurotoxin intoxication cascade. 
In addition, residues 59-89 (which encompasses the β-structure) seemed to be important for 
neurotoxicity as drawn from studies on structural comparison of notexin from Notechis 
scutatus scutatus, with other β-neurotoxins, and non-neurotoxic enzymes (Dufton and Hider, 
1983a; Kini and Iwanaga, 1986; Tsai et al., 1987; Kondo et al., 1989). More recently, Hains et 
al. (1999) developed a testable two-step proposal of neurotoxic PLA2 activity; involving the 
favourable binding to acceptor molecules followed by enzymatic intrusion upon the target 
membrane. 
 
1.4.3 Acetylcholinesterase inhibitors 
This group of neurotoxins cause continuous excitement of the muscle by binding to 
acetylcholinesterase and thus rendering acetylcholine unhydrolysed (Rodriguez-Ithurralde et 
al., 1981, 1983). Since they are capable of affecting transmitter turnover, they can be grouped 
as presynaptic neurotoxins (Harris, 1991). Acetylcholinesterase inhibitors have so far been 
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isolated only from African mambas (Dendroaspis), including fasciculin (Dajas et al., 1987) 
and F7 (Lin et al., 1987) from D. augusticeps and toxin C and D from D. polylepis polylepis 
(Joubert and Strydom, 1978; Karlsson et al., 1984). Structurally, they are related to cardiotoxin 
and α-neurotoxins. They consist of 57-60 amino acid residues in a single polypeptide chain, 
cross-linked by four disulfide bonds, showing similar primary structure to postsynaptic 
neurotoxins and cardiotoxins. In addition, they show similar 3-D structure as shown by the 
crystalline structure of fasciculin 2 (Le Du et al., 1989). However, they act by different mode 
from α-neurotoxins and cardiotoxins. Fasciculin 2 has no presynaptic action on transmitter 
release or on postsynaptic receptor-blocking action. Its main action is on acetylcholinesterase 
(Harvey et al., 1984; Anderson et al., 1985). By inhibiting acetylcholinesterase, fasciculin 
increased the amplitude and time course of the endplate potential (Lee et al., 1985) as well as 
the amplitude of the miniature endplate potential (Cervenansky et al., 1991). 
 
1.4.4 Potassium channel inhibitors  
 
Dendrotoxins are small proteins that were isolated 20 years ago from mamba snake venoms. 
Dendrotoxin is the first snake toxin found to bind voltage-sensitive K+ channel which is known 
to play an important role in the repolarization process in nerve transmission. In addition, three 
dendrotoxins (α-DaTX, β-DaTX, δ-DaTX) have also been isolated from the venom of D. 
augusticeps. Furthermore, toxin I (DTX14) from venom of D. polylepis polylepis and β-
bungarotoxin from venom of B. multicinctus have also been isolated.  
 
The functional effects of dendrotoxins have been well described in a review by Harvey (2001). 
The first noticeable effect of dendrotoxin is to facilitate transmitter release at peripheral 
synapses. Subsequently, the facilitatory effects of the dendrotoxins have been explained by 
their blockage of some neuronal K+ channels. This toxin has been suggested to block rapidly 
activating K+ current that is important for the control of the excitability of motor nerve 
terminals. When injected into the central nervous system, dendrotoxin induces epileptiform 
activity (Velluti et al., 1987; Coleman et al., 1992) and in high doses, can lead to neuronal 
damage (Bagetta et al., 1992; Mourre et al., 1997). In addition, dendrotoxin increases 
inhibitory postsynaptic currents in Purkinje regions of the mouse cerebellar slice preparations 
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(Harvey, 2001). Dendrotoxin also increases acetylcholine release in rat striatal slices, an effect 
attributed to the block of channels containing Kv1.2 subunits (Fischer and Saria, 1999). 
 
1.5 Postsynaptic neurotoxins  
 
Postsynaptic neurotoxins are those capable of blocking nerve transmission by binding 
specifically to nicotinic acetylcholine receptors located on the postsynaptic membranes of 
skeletal muscles and/ or of neurons. These toxins, which mimic the neuromuscular blocking 
effects of plant alkaloid, tubocurarine, but with approximately 15 – 20-fold greater affinity and 
poor reversibility of action, are also known as curaremimetic neurotoxins or simply as α-
neurotoxins, a suffix of historical significance (Chang, 1979; Chang, 1999). Most α-
neurotoxins are derived from Elapidae or Hydrophiidae snake venom and belong to the three-
finger toxin family. It must be emphasized that snake venoms are not the only exclusive source 
of α-neurotoxins. The venoms of marine cone snails also represent a rich combinatorial-like 
library of evolutionarily selected, neuropharmacologically active peptides called conotoxins 
that target a wide variety of receptors and ion channels. α-neurotoxins bear the imprint of a 
region of the nAChR that is likely to be in proximity to, and perhaps even overlap, the binding 
site for the natural neurotransmitter acetylcholine (Servent and Menez, 2001).  
 
1.5.1 Nicotinic acetylcholine receptor 
The discussion of α-neurotoxins will not be completed without a brief introduction to this well 
characterized receptor. The nAChR is perhaps one of the best characterized ion-channel to 
date, due in part to the discovery of α-bungarotoxin and a rich and accessible source of 
receptor from the electric ray and eel. Consequently, the mammalian neuromuscular junction is 
also the most studied and best understood synaptic region (Naguib et al., 2002). The nAChRs 
are transmembrane allosteric proteins of MW approximately 290 kDa that are involved in fast 
ionic responses to acetylcholine (Karlin et al., 2002). They are pentamers formed by the 
association of five subunits arranged symmetrically around the ionic pore in a plane 
perpendicular to the membrane (Miyazawa et al., 2003). Each subunit is composed of a large 
amino-terminal domain that contributes to the formation of the ligand binding pocket; four 
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membrane-spanning domains (MI, MII, MIII, MIV); a large and variable cytoplasmic loop 
between MIII and MIV; and a small extracellular carboxyl terminal.  
 
The MII domains of all five subunits contribute to the formation of the cation channel pore 
(Figures 1.4 A & B). In vertebrates, the combinatorial assembly of various nicotinic receptor 
subunits (α1- α10, β1- β4, δ, γ, and ε) generates a wide diversity of receptors, with various 
electrical and binding properties. Generally, nicotinic receptors can be divided into two main 
families: the muscle and neuronal nAChRs (Corringer et al., 2000). The well-characterized 
muscle receptor consists of a combination of α1, β1, δ and γ or ε subunits in the stoichiometry 
of (α1)2 β1 γ δ or (α1)2 β1 ε δ in the embryonic or adult receptor, respectively. These are 
densely distributed on the postsynaptic membrane of the neuromuscular junction and mediate 
intercellular communication between the nerve ending and skeletal muscle. The muscle-type 
receptor (α1)2 β1 γ δ is also found in abundance in the electric organ of the Torpedo ray. 
Neuronal nicotinic receptors are composed of α2 – α10 and β2 – β4 subunits. 
 
An excellent insights into the structure of nAChRs and ligand-gated ion channels in general, 
was made possible by the discovery and characterization of an acetylcholine-binding protein 
(AChBP) from the snail Lymnaea stagnalis (Figures 1.4C & D; Smit et al., 2001; Brejc et al., 
2001) which is a remarkable homologue of the amino-terminal extracellular domain of nAChR. 
The crystal structure of the AChBP revealed that each ligand-binding site is located in a cleft at 
the subunit interface, conforming to the existing biochemical and mutational data on nAChRs 
(Brejc et al., 2001). Based on the structure of AChBP, nearly all the residues of the agonist-
binding site of nAChR that were previously identified by photoaffinity labeling and 
mutagenesis experiments are located in the small cavity of about 10 – 12 Å diameter that is 
primarily formed by aromatic residues contributed by participating subunits (Grutter et al., 































Figure 1.4: The structure of nicotinic acetylcholine receptor and its binding protein. A: 
The nAChR is a pentamer of five homologous subunits. The muscle receptor of the 
stoichiometry (α1)2β1γδ is represented in this model. The receptor is depicted perpendicular to 
the axis of the ion channel pore. For clarity, the γ subunit is not shown. Each subunit is 
composed of four helical transmembrane domains (MI, MII, MIII, MIV). The MII domain of 
all five subunits lines the channel pore. B: Top view of the pentameric receptor, viewed along 
the five-fold axis, showing the association of the five subunits. The extracellular amino-
terminal domain of the α1-subunit and the adjacent subunit (γ or δ) cooperate to form two 
distinct binding pockets for acetylcholine (or other agonists or competitive agonists) at the 
interface between the subunits. C, D: The acetylcholine from binding protein from snail brain, 
a structural homologue of the nAChR ligand-binding domain. C: Each subunit is a single 
protein domain. The cavity and pocket at each interface likely constitutes the ligand binding 
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α-Neurotoxins from Elapid and Hydrophiid snake venoms belong to the three-finger toxin 
superfamily of non-enzymatic polypeptides containing 60 – 74 amino acid residues.  The 
characteristic feature of all three-finger toxins is their distinctive structure formed by three 
adjacent loops that emerge from a small, globular, hydrophobic core that is cross-linked by 
four conserved disulfide bridges (Endo and Tamiya, 1991; Menez, 1998). The three loops that 
project from the core region resemble three outstrectched fingers of the hand (Figure 1.5). The 
toxin is essentially a flat “leaf-like” molecule. In addition to the structural plasticity of the three 
fingers, the three-finger fold is also amenable to a variety of overt and subtle deviations, such 
as the number of the β-strands present, size of the loops and C-terminal tail as well as twists 
and turns of various loops, all of which may have great significance with respect to functional 
diversity and selectivity of molecular targets (Servent and Menez, 2001; Kini, 2002). Hence, 
despite the similar overall fold, three-finger toxins demonstrate an assorted range of 
pharmacological activities including, but not limited to, peripheral and central neurotoxicity, 
cytotoxicity, cardiotoxicity, inhibition of enzymes such as acetylcholinesterase and proteinases, 
hypotensive effect, and platelet aggregation (Tsetlin, 1999; Kini, 2002; Hodgson and 
Wickramaratna, 2002). It has been proposed that three finger scaffold is used by snake to target 












Figure 1.5: The 3D-structures of three-finger neurotoxins from snake venoms that interact with 
nicotinic acetylcholine receptors. The three-dimensional structures are shown in similar orientation 
and in line ribbon representation. Disulfide bridges are shown in black. The species names and the 
Protein Data Bank accession codes for structures are as follows: A: Erabutoxin-a (Laticauda 
semifasciata,5EBX, Corfield et al., 1989) B: Candoxin (Bungarus candidus, 1JGK, Paaventhan et al., 
A B C D 





2001)  C: α-Cobratoxin (Naja kaouthia, 2CTX, Betzel et al., 1991) D: α-Bungarotoxin (B. multicintus, 
2NBT, Sutcliffe et al., 1992). All are averaged NMR structures except erabutoxin-a, 2.0-Å crystal 
structure and α-cobratoxin, 2.4-Å-crystal structure. 
 
To date, more than 100 three-finger α-neurotoxins have been isolated and sequenced from 
Elapidae and Hydrophiidae snakes. Depending on their amino acid sequence and tertiary 
structures, α-neurotoxins can be classified into short-chain, long-chain, kappa and weak 
neurotoxins. Although the primary target of all these categories of the three-finger neurotoxins 
appears to be the muscle-type nAChR, some toxins are known to interact with other subtypes 
of nAChRs such as neuronal nAChR. 
 
 
1.5.3 Short- and long-chain neurotoxins 
 
Based on the length of their polypeptide chains, α-neurotoxins were initially classified as short-
chain α-neurotoxins that have 60 – 62 residues and four conserved disulfide bonds in common 
positions, between Cys-3 and Cys-24, Cys-17 and Cys-45, Cys-40 and Cys-61, Cys-62 and 
Cys-68 (Figure 1.5A). These neurotoxins bind with high affinity to muscular-type nAChRs.  
 
The second group constitutes the long-chain α-neurotoxins consisting of 66 – 70 amino acid 
residues with disulfide bonds, the fifth being between Cys-30 and Cys-34, in addition to the 
four disulfide binds that are common in short-chain α-neurotoxins (Figure 1.5C). 
Notwithstanding their classification a short-chain and long-chain neurotoxins, both types of α-
neurotoxins bind with high affinity to the Torpedo or muscle (α1)2β1γδ nAChRs (Servent and 
Menez, 2001). Nonetheless, it has been reported that short-chain α-neurotoxins tend to 
associate with the nAChR 6 – 7 fold faster and dissociate 5 – 9 fold faster than long-chain α-
neurotoxins (Chicheportiche et al., 1975). Apart from differences in structure, long-chain but 
not short-chain α-neurotoxins are also able to bind with high affinity (Kd approximately 10-8 – 
10-9 M) to neuronal homopentameric α7, α8 and α9 nicotinic receptors (Servent et al., 2000; 






1.5.4 Kappa neurotoxins 
 
κ-Neurotoxins form a new family of snake venom neurotoxins that are structurally related to 
long neurotoxins. With the exception of κ-cobrotoxin, all the other κ-neurotoxins identified 
consist of 66 amino acid residues and on the basis of amino acid alignment, contain five 
disulphide bonds as in long neurotoxins (Figure 1.5D).  The first κ-neurotoxin, κ-bungarotoxin 
was purified from B. multicinctus venom and it is a minor component representing only 0.1% 
of total venom (Grant and Chiapinelli, 1985). κ-bungarotoxin exists in physiological solution 
as a dimer of identical subunits, each subunit having a molecular weight about 7.3 kDa. The 
dimer is not covalently linked and is dissociated into monomers in the presence of sodium 
dodecyl sulfate, urea, or high-ionic strength and high-pH buffers (Chiappinelli et al., 1985), in 
contrast to monomeric α-neurotoxins either in solution or in crystal.  
 
All κ-neurotoxins also contain the amino acid deletions in positions 16 – 20 and amino acid 
additions between positions 36 and 40, which are characteristic of long neurotoxins (Fiordalisi, 
1994). Moreover, the κ-neurotoxins display a unique single-residue insertion in position 52 
(Fiordalisi, 1994). These toxins have shorter carboxyl-terminal tail than any other long chain α-
neurotoxins. κ-Neurotoxins bind with high affinity to the α3-containing neuronal nAChRs and 
with low affinity to the α4-subunit-containing neuronal nAChR (Chiappinelli, 1992).  Contrary 
to short and long neurotoxins, κ-neurotoxins are weak antagonists to muscle-type nAChR 
(Grant et al., 1985; Dewan et al., 1994; Sutcliffe et al., 1992)  The absence of Trp-32 in all the 
κ-neurotoxins could be the reason for the lack of binding to muscle-type nAChR (Grant, 1988). 
To date, this group contains nine members isolated from Bungarus (Grant et al., 1985) and one 
from Naja (Chang et al., 1998). The exact basis of the distinct physiological selectivity of these 
structurally-similar α- and κ-neurotoxins is not well understood.  
 
1.5.5 Weak neurotoxins 
 
Weak neurotoxins, also known as atypical or miscellaneous toxins, constitute another class of 
three-finger toxins that consist of 62 – 68 amino acid residues and five disulfide bridges. 
However, unlike long-chain α-neurotoxins and κ-neurotoxins, the fifth disulfide bridge in weak 
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neurotoxins is located in loop I (N-terminus loop, Figure 1.4B). Weak toxins are typically 
characterized by a lower order of toxicity with lethal dose (LD50) varying from 5 – 80 mg/ kg 
as opposed to prototypical α-neurotoxins with LD50 approximately 0.04 – 0.3 mg/ kg.  Weak 
neurotoxins from cobra venoms such as WTX (Naja kaouthia) and Wntx-5 (N. sputatrix) 
produced a weak inhibition of muscle nAChRs in micromolar inhibitory concentrations (Utkin 
et al., 2001; Poh et al., 2002). Candoxin from B. candidus was a potent inhibitor of muscle 
nAChRs in low nanomolar range (IC50 approximately 10 nM). This toxin was also found to 
inhibit neuronal α7 nAChRs at low nanomolar (IC50 approximately 50 nM) inhibitory 
concentration (Nirthanan et al., 2002). It is conceivable that weak neurotoxins that bind weakly 
to muscle nAChRs may yet have other unidentified molecular targets.  
 
1.6 Applications of snake venom neurotoxins in research and therapy 
 
Although early venom research was motivated by the desire for satisfactory cures for snake 
envenomation, the general perspectives on animal toxins have changed dramatically due to the 
accumulating data that has revealed a far wider scope for these natural biomolecules. It has 
been 40 years since it was first realized that the physiologically active components of snake 
venoms might have therapeutic potentials (Senior, 1999). These biomolecules have assumed 
great importance as molecular probes and pharmacological tools to investigate the functional 
biology of receptors and ion channels as well as providing lead compounds for the design of 
clinically useful drugs (Harvey et al., 1998; Harvey, 2002a, b).  
 
There is perhaps no better example to highlight the significant contributions made by venom 
peptides to science and medicine than the discovery of α-bungarotoxin from Taiwan banded 
krait, which has spawned the field molecular pharmacology by enabling the isolation and 
characterization of nAChR from electric eel and other sources (Chang and Lee, 1963; Lee, 
1972). 
 
1.6.1 Viral infection 
The possibility that nAChR is a host cell receptor for the neurotropic rabies virus was first 
discussed by Lentz et al. (1982). These authors suggest that the virus binds at neuromuscular 
junction and the binding is drastically reduced by the specific AChR antagonist α-
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bungarotoxin (α-Bgt). A stricking homology between a region of rabies virus glycoprotein and 
the putative functional sites of snake venom neurotoxin has been demonstrated by Lentz et al. 
(1984). This would imply a functional convergence between these distantly related proteins.  
Purified rabies virus glycoprotein was able to compete with the potent neurotoxin of snake B. 
multicinctus α-bungarotoxin for binding to acetylcholine receptor.  Moreover, anti-peptide 
monoclonal antibodies against glycoprotein 190-203 had been found to efficiently inhibit the 
binding of both rabies virus glycoprotein and α-bgt to acetylcholine receptor. In general, the 
regions of virus molecules involved in binding to the cellular components acting as viral 
receptors might be structurally similar to the binding domains of cellular proteins that normally 
bind to the cell components (Figure 1.6). Such similarity between parts of viruses and ligands 
or normal cell constituents may provide a basis for the pathogenesis of some autoimmune 
diseases because viral infection could be followed by production of antibodies to the idiotypes, 
which would react with the cellular structures (Sege et al., 1983). Identification of the viral 
domains that bind to cells should be important in the treatment of viral diseases.  
 
Neri et al. (1990) also reported the homology of the neurotoxin toxic loop with the sequence of 
164-174 of HIV-1 gp120. Human rhabdomyosarcoma cell line, TE671, is known to express a 
muscle-like nicotinic receptor (Schoepfer et al., 1988) to which α-bungarotoxin binds with high 
affinity. The binding of α-bungarotoxin to TE671 cells was found to be inhibited by gp120 
from HIV-1 strain IIIB. Therefore, HIV infection of muscular and neuronal cells in vitro might 
be mediated by gp120 binding to nicotinic acetylcholine receptor present in these cells; which 
raises the same possibility that the same mechanism may be observed for HIV neurotropism. 
The results suggest that nAChR may also bind HIV-1 gp120 in neuronal cells since α-bgt 





















Figure 1.6: A model showing homology of rabies glycoprotein with the “toxic” loop of the 
neurotoxins. The segment of the glycoprotein (residues 174 to 202) corresponding to loop 2 of 
the long neurotoxins (position 25 to 44) as determined by computer modeling is positioned 
relative to a schematic representation of loop 2. Within circles, residues or gaps in the 
glycoprotein are shown on the left and those in the neurotoxin on the right. One letter in the 
circle implied the same residue in glycoprotein and toxin. Bold circles are residues highly 
conserved or invariant among all the neurotoxins. A ten-residue insertion in the glycoprotein is 
enclosed in the box. The rabies virus sequence is from CVS strain. Neurotoxin sequence is 
from Ophiophagus hannah, toxin b (inset). Schematic representation of neurotoxin structure 
showing positions of loops 1, 2 and 3 (Lentz et al., 1984).   
 
1.6.2 Myasthenia gravis 
 
α-Bgt played an important role in understanding the pathogenesis of myasthenia gravis (MG), a 
disease which causes weakness of skeletal muscles. Muscular tissue of patients exhibited a 
considerably reduced number of nAChR sites available for toxin binding (Mebs, 1989). The 
autoimmune nature of the disease became evident when animals immunized with isolated 
nAChR developed symptoms essentially identical to MG. It became clear that an autoimmune 
attack directed to the body’s own nAChR causes accelerated degradation of these receptors in 




markers and blockers of those neuronal AChRs and perhaps weak neurotoxins can be used as 
potential tools to answer this question.  
 
1.6.3 Alzheimer’s disease 
 
Recently, Nirthanan et al.  (2002) identified candoxin from B.  candidus as a reversible 
antagonist of muscle nicotinic acetylcholine receptors and an irreversible ligand to neuronal 
nicotinic acetylcholine receptor.  This compound may be useful as a probe to label, identify or 
isolate the α7-subtype of neuronal nicotinic receptor, in which this receptor is of great interest 
in several disease conditions such as Alzheimer’s disease. The rapid onset and reversible 
properties of candoxin, like d-tubocurarine which is used as a muscle relaxant, can be exploited 
for therapeutic use. 
 
1.6.4 Thrombotic disease 
 
A potent glycoprotein from Dendroaspis jamesonii which is structurally related to short 
neurotoxins was discovered by McDowell et al. (1982) to be platelet aggregation inhibitor. The 
finding that an Elapidae snake has a protein with the general structure of a neurotoxin but with 
the function of platelet inhibitor, is unique and have important implications for evolutionary 
biology. This unique inhibitor named mambin is non-neurotoxic and may have therapeutic 
potential for treatment of thrombotic disease (McDowell et al., 1982). 
 
1.6.5 Research tools 
 
Muscle nAChRs are pseudosymmetric pentameric complexes formed by four different subunits 
(α, β,  γ or ε and δ) whereas neuronal nAChRs identified so far are pentamers formed by one 
(αx), two (αx, βγ) or three (αx, αy, βz)  types of subunits (McLane et al., 1993). Neuronal 
nAChRs, in addition to having alternative subunit stiochiometries, are composed of several 
different subunit subtypes, with at least eight different α subunits and five different β subunits 




By far, the most valuable probes to characterize muscle nAChR are long and short neurotoxins 
from snakes which bind with extremely high affinity (KD = 10-12 – 10-9 M) to skeletal muscle 
nAChRs (Chiappinelli, 1991). Occupation of the toxin of either one or both of the ACh 
recognition sites on the α subunits of a muscle receptor prevents the ion channel associated 
with the receptor from opening in response to cholinergic agonists (Neubig and Cohen, 1980).  
In addition, long neurotoxins have been used to characterize neuronal nAChRs containing α7 
subunits (Seguela et al., 1993). These neuronal receptors have a high affinity for the long 
neurotoxins at KD = 0.7-1.7nM (Tindall et al., 1978; Wolf et al., 1988). For example, α-
bungarotoxin has been an important antagonist in establishing the functional properties of these 
neuronal AChRs (Zhang et al., 1994). The α-bungarotoxin-sensitive neuronal receptors have 
certain properties unlike other AChRs such as the ability to form functional homomeric 
channels in oocyte expression studies and high permeability to Ca2+ ions (Seguela et al., 1993; 
Alkondon et al, 1993). 
 
κ-Neurotoxins are selective and potent antagonists used to characterize neuronal nAChRs in 
which short and long neurotoxins have no effect (Chiapianelli, 1991). For example, κ-
bungarotoxin had been used as a potent inhibitor of α3β2 neuronal nAChRs (McLane et al., 
1993). 
 
One of the many applications of toxin as a probe was exploited by Sekhon et al. (1999). They 
tested their hypothesis that maternal smoking during pregnancy is associated with alterations in 
pulmonary function at birth and increase respiratory illnesses after birth. They found that the 
direct results of these observations are due to nicotine binding with nAChRs. Labeled α-
bungarotoxin was used to label α7 nAChRs in developing monkey lung and the results 
demonstrated that nicotine significantly increased α7 nAChRs in airway epithelial cells, 
alveolar type II cells, alveolar macrophages and pulmonary neuroendocrine cells (PNEC). 
Hence the use of labeled neurotoxin in this study can contribute to the understanding of 
mechanistic changes that occur in the fetus of smoking mothers.  
 
The role(s) of weak neurotoxin in the venom is still unknown and the challenge now is to fully 
unravel its physiological importance in the snake.  
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1.6.6 Novel functional homologs 
 
Miwa et al., (1999) discovered a novel, endogenous homolog of snake neurotoxins, lynx1 in 
mouse cerebellum, hippocampus, and cortex. This new relative of the family of elapid 
neurotoxins was identified in the course of a search for developmentally regulated genes in the 
cerebellum. Based on overall sequence similarity, conservation of cysteine-rich consensus 
motif, and common gene structure with neurotoxin gene, lynx1 was classified as a small 
(11kD) toxin-like (prototoxin) central nervous system protein (Figures 1.7A and B).  In 
contrast to secreted snake neurotoxin, lynx1 is normally present at the cell surface as a 
glycophosphatidylinositol (GPI)-anchored protein (Miwa et al., 1999). Further studies found 
that this protein could associate and modulate nAChR, exhibiting preferential binding to α7 
and α4 subunits (Ibanez-Tallon et al., 2002). Studies on mice carrying lynx1 null mutations 












Figure 1.7: Comparison of the lynx1 model and the αBgt experimental structure. (A) The 
figure shows the three-dimensional model of lynx1. Strands are shown as green arrows and 
disulfide bridges are coloured yellow. (B) Experimental NMR structure of α-Bgt (PDB 1abt). 
The orientation and colouring is the same as for lynx1. N- and C-terminal ends of both 





1.6.7 Chimeric toxins 
 
It was observed that when a long neurotoxin whose characteristic fifth disulphide bond was 
selectively reduced, it behaved like a short neurotoxin in terms of specificity of receptor 
recognition (Servent et al., 1998). Addition of a fifth disulphide bond at the tip of the central 
loop of a short neurotoxin increases its affinity for neuronal receptors. Ricciardi et al. (2000) 
tested the idea that structural deviations between toxins adapting the same fold reflect 
functional diversity. They also demonstrated that when a recombinant fasciculin/ toxin α 
chimera containing loop 1 and tip of loop 2 of fasciculin was transferred into toxin α, the 
chimera exhibited nearly all acetylcholinesterase-blocking activites of fasciculins (Ricciardi et 
al., 2000). This would imply that toxin usually adopt a limited structural deviations which can 
result in a multiple functional diversity. 
 
1.7 Scorpion  
 
Scorpions belong to arthropods in the animal kingdom and they are the largest as well as the 
oldest arachids. They are representated by 1, 500 distinct species. To date, scorpions have a 
wide geographical distribution and live on all major land masses except Antarctica. Their 
habitats include desert, savanna, grasslands, temperate forests, tropical forests, rain forests and 
the intertidal zones. Some remarkable species are found even at snow-covered mountain over 
5, 500 m in altitude and in caves at depth of more than 800 m (Francke, 1982).  
 
Scorpions can be divided into six families: Bothriuridae, Scorpionidae, Buthidae, Vejovidae, 
Chlaerilidae and Chactidae. Only Buthidae scorpions produce neurotoxic secretions. 
Scorpions which are dangerous to humans are found in desert or semiarid regions throughout 
the world. Among the approximately 1500 scorpion species, only about 25 species are of 
medical importance. Morbidity and mortality rates due to scorpion stings are especially high in 
children have been reported in various countries. In Mexico, Brazil, North Africa, India and in 
the Middle East (Mazzotti, 1963; Bucherl, 1971; Balozet, 1971; Bawaskar, 1989), scorpions 





1.7.1 Buthus martensi Karsch  
 
The Chinese scorpion Buthus martensi Karsch (BmK) belonging to the Buthidae family is 
widely distributed from northwestern China to Mongolia and Korea. The sting by this species 
can cause excruciating local pain that might last for several hours and induce a series of 
inflammation and pain responses (Balozet, 1971; Bai et al., 2003). They can grow up to 4.8 – 
5.2 cm in length. As early as one thousand years ago, the pharmaceutical role of scorpions was 
widely recognized by the Chinese. Li Shi-Zhen in 1578 described the properties and curative 
effects of scorpions in detail. In Traditional Chinese Medicine at this present time, the whole 
scorpion body especially the tail, is being used as a medicine to treat neuromuscular diseases 
such as paralysis and epilepsy. In addition, scorpions have been used for treatment in apoplexy, 
hemiplegic and facial paralysis.  
 
Detailed knowledge about the biological properties of the venom of BmK has been generally 
limited and only little is known about the neurotoxic components present in the venom of this 
species. In the past years, BmK venoms has been studied extensively and this lead to the 
discovery of 77 different peptides (Goudet et al., 2002).  
 
1.7.2 Scorpion venom  
 
Scorpions produce powerful venom in glands located in the distal end of its tail, known the 
telson. The venom is injected into a victim through a sharp stinger. Scorpion venoms are lethal 
to a broad spectrum of animals such as rodents (rats, mice and guinea pigs), rabbits, chicks, 
fish, arthropods (fly larvae, crickets, moths and mealworm) and many others. There are 
however, a few animals which are resistant to scorpions venoms such as the tarantula spider, 
locust and of course, scorpions themselves.  
 
Although Chinese scorpion is generally not dangerous to human, the venom is considered to be 
a mixture of ‘rather active toxins’, suggesting that it had probably several toxic components 
(Balozet, 1971). The toxicity (LD50, i.p) of this venom in mice was found to be 3.38 mg/ kg 
weight (Gong et al., 1992), which is moderate in comparison with the LD50 of the venoms of 
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other species. BmK venoms induce convulsions and paralysis in mammals, crusteacea and 
insects. 
 
Scorpion venoms, like the snake venom contain a complex protein composition. They consist 
of mucopolysaccharides, small amounts of hyaluronidase and phospholipases, low molecular 
weight compounds such as noraderenaline, serotonin,  histamine, protease inhibitors and 
histamine releasers and multiple basic, predominantly neurotoxic proteins (Simard and Watt, 
1990; Martin-Eauclaire and Courad, 1995;). The scorpion venom contains an array of several 
structurally distinct families of peptides that modulate ion channels. These toxins can be 
classified into four groups according to their effects on specific ion channels, such as Na+, K+, 
Ca2+ and Cl- ion channels (Garcia et al., 1997; Gordon et al., 1998; Tytgat et al., 1999; 
Valdivia and Possani, 1998; Possani et al., 1999). 
 
Ion channels are crucial elements for the activity of living cells, targeting these membrane-
bound proteins is thus an efficient means for venomous animals to capture their preys or to 
defend themselves against enemies. Natural toxins also provide powerful tools for 
understanding the physiological contribution of ion channels to cell and organ behaviour and 
for probing and correlating ion channel structure and function. Moreover, elucidation of the 
mechanisms of toxin action especially on their three-dimensional structures provide wider 
perspectives in designing of drugs (Menez, 1998). 
 
The best studied peptides are long-chain toxins that contain 60 – 70 amino acids residues with 
four disulfide bridges (Possani, 1984). The targets of these toxins are voltage-sensitive Na+ 
channels of excitable muscle and nerve cells. These ion channel toxins can be divided into α-
toxins and β-toxins, based on their physiological effect on the opening and closing kinetics of 
Na+ channels. The α-toxins prolong the action potential by blocking Na+ channel inactivation 
and β-toxins shift the voltage activation towards a more negative potential thereby affecting 
Na+ channel activation and promoting spontaneous and repetitive firing (Couraud et al., 1982; 




The difference in the effects of the α- and β-toxins is attributed to their ability to bind to two 
distinct sites on the Na+ channel receptor. α- and β-toxins bind to sites 3 and 4 on the Na+ 
channel respectively (Jover et al, 1980). Alternatively, Na+ channel toxins classified based on 
their species specificity as insect-, mammal-, and crustacean-specific toxins (Gordon et al., 
1996; Meves et al., 1984; Garcia et al., 1997). An exception to this rule is toxin AaH IT4 
which is cross-species specific affecting both insects and mammals (Loret et al., 1991). 
Hundreds of distinct peptides specific for Na+ channels have been purified from 20 – 30 
species of scorpions; at least 120 complete primary structures have been identified.  
 
On the other hand, a subset of short-chain scorpion toxins has also been found to interact with 
the voltage-dependent or Ca2+-activated K+ channels or with Cl- channels. Toxins that affect 
voltage-gated K+ toxins typically contain 31 – 38 amino acids with three or four disulfide 
bridges (Garcia et al., 1997). A recently purified 23-residue toxin from the scorpion Tityus 
cambridgei was reported to block K+ channel (Batista et al., 2000). Two scorpion peptides 
have been reported to modify the binding of ryanodine to Ca2+ - channels. Imperatoxin A, 
which is 33 amino acids long, increases the binding of ryanodine resulting in continuous Ca2+ 
channel stimulation (Zamudio et al., 1997a). Imperatoxin I is a heterodimer which blocks Ca2+- 
channel by inhibition of ryanodine binding (Zamudio et al., 1997b).  
 
Scorpion toxins that interact with Cl- channels and their homolog are approximately 36 amino 
acids long with four disulfide bridges (Lippens et al;, 1995; DeBin et al., 1993). Chlorotoxin is 
the first high-affinity peptide ligand for Cl- channels. In recent years, Cl- channel have been a 





A microarray is an ordered array of microscopic elements that allows specific binding of genes 
or gene products. Microarray is a new scientific word derived from the Greek word mikro 
(small) and the French word arayer (arranged).  Microarrays, also known as biochips, DNA 
chips and gene chips contain minute quantities of DNA, protein or small organic compounds 
which can be probed with possible binding ligands. The first use of microarray was in 
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immunological assays but progress in genome sequencing has created a demand for 
simultaneous multi-gene analysis (Ekins, 1989; Ekins and Chu, 1992).  
 
Microarray technology developed in the early 1990s by Mark Schena and collegues at Stanford 
University rely heavily on six major disciplines: biology, chemistry, physics, engineering, 
mathematics and computer science (Schena et al., 1995). The advent of this miniaturized 
technology for the study of molecule-molecule interactions has changed the way that new 
challenges are approached in cell biology. In addition, major advances in detecting 
fluorescence-based experiment had enabled simultaneous analysis of thousands of variables in 
a single experiment (Howbrook et al., 2003). 
 
1.8.1 DNA microarray 
 
Array-based gene expression analysis in which immobilized DNA probes hybridizing to RNA 
and cDNA targets has become an important primary tool in many research projects. Expression 
analysis for the quantitative gene expression of many genes can be performed using one- or 
two-color fluorescent schemes. One colour analysis is primarily used for arrays prepared using 
photolithography method. In 1991, Fodor described an innovative application of 
photolithography, which has been used in the industrial production of electronic semiconductor 
devices. Photolithography uses ultraviolet light and solid-phase synthesis to manufacture 
microarray (Fodor et al., 1991). This light-based synthesis approached became one of the 
widely used methods in the manufacture of microarray. Briefly, we attached synthetic linker 
modified with photochemically removable protecting groups to a glass substrate and direct 
light through a photolithographic mask to specific areas on the surface to produce localized 
photodeprotection. The first series of chemical building block is incubated with the surface and 
chemical coupling occurs at those sites that have been illuminated in the preceding step. Next, 
light is beamed to different regions of the substrate by a new mask and chemical cycle is 
repeated (Pirrung et al., 1998). Photolithography allows the construction of arrays with 
extremely high information content. Since the arrays are constructed on a rigid material (glass), 


























Figure 1.8:  Flowchart showing a typical microarray experimental procedure. After 
carrying out the biological experiment, the samples from tissues or cells, are collected. For 
example, sample A is the control experiment and sample B is the tested experiment. Total 
RNA is isolated and labeled with fluorescent dyes and co-hybridized with the microarray. The 
hybridized microarray is scanned to acquire the fluorescent images. Statistical analysis can be 
used to infer the microarray data, depending on one’s aim of study. Image adapted from Leung 
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chamber (Lipshutz et al., 1999). A fluorescently tagged nucleic acid sample injected into the 
chamber is allowed to hybridize to the complementary oligonucleotides on the array. Laser 
excitation enters through the back of the glass support and focused at the interface of the array 
surface and target solution. The fluorescence emission caused is collected by a lens and passed 
through a series of optical filters to a sensitive detector which converts it to a quantitative two-
dimensional fluorescence image (Ekins, 1989; Ekins and Chu, 1992).  A summary of a typical 
microarray experiment is depicted in Figure 1.8.  
 
1.8.2 Applications of DNA microarray 
 
Gene expression studies using DNA microarray accounts for 81% of the scientific 
publications to date, but microarrays are being used for many other purposes including 
genotyping, tissue analysis, and protein studies. In the field of development, microarrays can 
be employed to build a database of gene expression levels as a function of cell and tissue type. 
These databases are extremely valuable as they provide deeper understanding of the basic 
mechanisms that control multicellular development and might shed some insights into the 
pathological cellular events, including the onset and progression of human disease.  
 
The onset and progression of human disease are determined by a complex set of factors, 
including genetics, diet, the environment, and the presence of infectious agents. Microarray 
makes a unique tool in studying each of these contributing factors. For example, gene 
expression patterns in brain tissue from normal individuals and Alzheimer’s patients can be 
studied to elucidate the genetic basis of this illness. Almost all human diseases can be studied 
using microarray analysis and the ultimate goal of this work is to develop treatments or cures 
for every human disease by 2050 (Schena, 2003).  
 
Drug discovery is one of the hottest areas in research and development. Many known drugs 
impart their therapeutic activity by binding to specific cellular targets, inhibiting protein 
function, and altering the expression of cellular genes. In principle, it is possible to use 
microarray for drug discovery and clinical trials by generating gene expression profiles in 
patients undergoing disease progression or drug treatment. Many illnesses lead to specific  
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changes in gene expression and drugs that reverse these changes might be beneficial. 
Expression profiling may be useful in identifying drugs that alter gene expression of nontarget 
genes, as a means of identifying drugs with possible side effects. This might lead to safer 
medicines with minimal side effects. In addition, this technology can be used for patient 
genotyping, and the capacity to partition the population into drug responders and 
nonresponders based on genotype may enable more personalized medicine.  
 
Microarray has also been successfully used for providing the biological and medical 
community with a greater understanding of venom – induced pathologies and the subsequent 
treatment of envenoming (Gallagher et al., 2003). This microarray – based toxicological 
approach was employed in vivo to investigate the effects of phospholipase A2 from Naja 
sputatrix to study the change in global gene expression especially on aquaporins and Na+/ K+- 
ATPase genes (Cher et al., 2003). Another group used an in vitro system to study venom-
induced apoptosis in human umbilical vein endothelial cells by use of subpathological levels of 
Crotalus atrox and Bothrops jararaca (Gallagher et al., 2003). These studies collectively 
demonstrate that snake venom components can be used as biologically active proteins in 




The pioneering neuroscientist Ramon y Cajal (1928) observed that: 
 
“In adult centers the nerve paths are something fixed, ended, immutable. Everything may die, 
nothing may be regenerated. It is for the science of the future to change, if possible, this harsh 
decree.” 
 
The mature central nervous system (CNS) was distinguished from the developing nervous 
system by the lack of growth and cellular regeneration. The fixed neuronal population of the 
adult brain was understood for necessary maintenance of functional brain circuitry. This might 





However, in the last several decades, mounting evidence has led to the view of the CNS as a 
dynamic, plastic organ, endowed with some potential for self-repair and regeneration. Great 
progress have been made in the understanding of continued neurogenesis in adult brain and this 
has raised hopes that self-renewal leading to structural repair by neurons may be possible in 
new neurons (Hallbergson et al., 2003). 
 
Neurogenesis in the adult brain can be divided into three phases in accordance with the 
sequence of neurogenesis during CNS development: (a) proliferation, where new cells are 
generated; (b) migration towards the target areas; and (c) terminal differentiation into distinct 
phenotypes (Hallbergson et al., 2003).  
 
Neurogenesis is a term which implies progression through differentiation and not only where 
cases of proliferation is studied. Studies have found that new functional neurons are generated 
in two adult germinal centres, adding further complexity to the definition of adult plasticity to 
include circuitry (van Praag et al., 2002). 
 
An important observation showed that adult neurogenesis is not static but indeed responds to 
environmental factors such as physical activity, environmental enrichment, caloric restriction 
and modulation of neural activity (Peterson, 2002; Ray and Peterson, 2002). The 
responsiveness of adult neurogenesis to environmental influences may suggest that its 
regulation is under the control of expressed factors whose level of availability dictates the rate 
of neurogenesis (Hallbergson et al., 2003). 
 
The spatial and temporal expression of various trophic or growth factors play a role in guiding 
cell-fate choices and determine the size of the neuronal population. In addition to protecting 
neurons, trophic factors have been shown to stimulate proliferation of adult-derived stem cells 
and to instruct their differentiation. Examples of trophic factors include amphiregulin and 
fibroblast growth factor (FGF) (Kuhn et al., 1997, Zigova et al., 1998; Pencea et al., 2001; 
Benraiss et al., 2001; Falk et al., 2002). Amphiregulin is part of the family of endothelial 
growth factor (EGF) protein and it has have been suggested to play a role in stem cell 
proliferation and  neurogenesis in the adult brain (Falk et al., 2002). FGF-2 on the other hand, 
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is another potent mitogen for a variety of cells and modulates embryonic development and 
differentiation, adult angiogenesis, wound healing and tissue repair. In the brain, FGF-2 is 
important as a survival factor and is neuroprotective against a variety of insults (Peterson and 
Gage, 1999).  
 
So far, about 70 toxins from BmK have been identified. They are mostly α and β-toxins as well 
as toxins blocking K+ and Cl- channels. These toxins have been identified mostly using 
conventional method such as proteomics. It would be interesting to see if BmK might have any 
pharmacologically important factors that can affect neurogenesis in human brain cells.  
 
 
1.10 Database creation 
 
The first characterization of α-bungarotoxin 40 years ago led to a boom in the discovery of 
other similar snake neurotoxins.  In 1990, there are about 100 known neurotoxin protein 
sequences in GenBank. However, to date, there are approximately 555 neurotoxin entries in 
public databases, from snake venom alone. Therefore, the accumulation of snake venom 
neurotoxins (svNTXs) had greatly increased over the years and this makes it an attractive 
bioinformatics study for further functional and structural characterizations of svNTXs.  
 
Established methods of determining functions of svNTXs are based on study of chemical 
mutagenesis (reviewed by Karlsson, 1979), structural studies (reviewed by Dufton and Hider, 
1983b) and pharmacological and biochemical characterization experiments (Endo and Tamiya, 
1991). Many research groups have focused on isolating, purifying and characterizing 
individual toxins or small groups of toxins. The number of characterized svNTXs reported in 
the literature and molecular databases is increasing rapidly. In addition, functional properties of 
individual svNTXs are poorly annotated in molecular databases. Insufficient cross-linking 
between databases leads to redundancy and often conflicting information, indicating potential 
errors in data.  
 
The growing number of well-studied svNTXs and the high complexity of related information, 
such as their structural and functional properties have created a need for improved data 
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management. The analysis of svNTXs data is growing increasingly complex and there is a need 
for a single, well annotated, and cleaned database, which will facilitate svNTXs analysis. 
 
Data for the study of svNTXs are scattered across multiple sources. Hence, there is a need for 
specialized database in svNTXs to be used as a tool for the study of svNTXs. The database 
contains entries collected from different sources, organized, analysed and classified according 
to their structure-function relationship. The svNTXs were annotated for their pharmacological 
properties and enzymatic activity from literature sources. From the data, pharmacological 
groups were formed to classify svNTXs based on structure and function relationship. This 
general classification of svNTXs can be used to identify putative residues for each 
pharmacological property by sequence comparison between the groups. Well organized and 
rich data allow the use of sophisticated tools for improved structure-function analysis.  
 
1.10.1 Current problems with analysis of snake toxins using bioinformatic resources 
 
Current data on svNTXs are deposited in public repositories GenBank, EMBL (Stoesser et al., 
2001), DDBJ (Tateno et al., 2000), SwissProt, and PIR (Barker et al., 2001). The svNTXs 
three dimensional structures are deposited in the PDB database. Functional properties of 
svNTXs can be found mainly in published articles while functional annotation of sequences in 
public sequence databases is very limited (Brusic et al., 2000). Structural properties of some 
svNTXs can be found in the PDB database and published articles. Of 272 svNTXs reported in 
February 2004, 1.5% have been published in journals articles only, and the remaining 98.5% 
have been found in public databases. 
 
A recent analysis on scorpion toxin data (Srinivasan et al., 2002) from public databases 
revealed the presence of numerous errors in the sequences, incomplete data, poor annotation 
and discrepancies of information for the same entry from different sources. For example, some 
of the errors encountered were wrong link between databases, different names for the same 
sequence, different sequences for the same toxin and absence of link between databases. In 
order to minimize these errors, certain measures such as cross-checking with original 
publications were taken. In the context of all known data, a unified classification of svNTXs 
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does not exist. Detailed classification based on structure-function relationship was also 
constructed. Several bioinformatics tools for analysis of biological data include: 1) pairwise 
sequence alignment, ii) multiple sequence alignment (local and global), ii) phylogenetic 
analysis, iii) 3-D structure analysis. 
 
i) Pairwise alignment is carried out to locate the conserved regions between two 
sequences. In global alignment, entire sequences are aligned at the same time using 
extension of dynamic programming, while in local alignment, conserved regions are 
found by statistical methods, derived by removing stretches of global alignment. 
BLAST 2.0 (Altschul et al., 1997) and CLUSTAL X 1.82 are used for local and 
global alignment respectively. 
ii) Multiple sequences alignment is the hierarchical extension of pairwise alignment. 
They are widely used to identify conserved motifs and to predict functional role. It 
is also a basis for phylogenetic analysis. 



























1.11 Aims of the project 
 
 
The aim of this project has been divided into two parts. The initial part of the project has been 
to build a snake venom neurotoxin database. 
 
The specific goals are: 
 
1) To build a clean information enriched database for svNTXs. 
2) To classify toxins based on their structure and function relationships. 
3) To provide an in-house platform to predict function of new toxins. 
 
 
The second aim of the project has been to screen for potential therapeutic agent(s) in the 
venom of Chinese scorpion, Buthus martensi Karsch (BmK) using DNA microarray and real-
time PCR. The motivation is to elucidate some of the biological basis of using scorpion venom 
in traditional medicine. This scorpion venom has been found to have effects on the 
cardiomuscular system (Gong et al, 1992) in addition to having analgesic effect and antitumor 
activity (Liu and Pei, 1989; Zhang et al., 1987). It will be interesting to discover novel drug 
leads in this well studied scorpion.  
 
The specific goals are: 
 
1) To examine the subtoxic effects of venoms on gene expression on human 
neuroblastoma cells and to highlight its potential use in the drug discovery. 
2) To screen for active fraction(s) in the venom affecting the expression of genes involved 
in neurogenesis and angiogenesis using real-time PCR. 
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                                       CHAPTER TWO 
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2.2 Data collection and cleaning 
Structural and functional data in svNTX database where obtained from various sources. Protein 
sequences information was gathered from public databases such as GenBank, SwissProt and 
EMBL.  The three dimensional (3-D) structures of svNTXs were extracted from PDB. The 
BioWare system available on-line at http://sdmc.a-star.i2r.org.sg/Templar from Institute for 
Infocomm Research (I2R) was used to facilitate data retrieval from public databases. 
 
Protein sequence entries were gathered from the public databases by query ‘Serpentes and 
neurotoxin’ using keyword search via BioWare Retrieve module. The return result, a raw data 
set, underwent a preliminary filtering to remove irrelevant records, such as neurotoxins from 
other species and neurotoxin fragments. Records not selected at this step were recorded into a 
rejected list by BioWare to avoid future retrieval of the same entry during database updates. The 
raw data set after preliminary filtering will be referred to as the initial data set.  
 
Data from various databases vary in format. There was a need to integrate these data into one 
single format. Therefore the data were merged and formulated for the BioWare integrated format.  
 
The final preliminary data set was next checked for duplicate entries. This was facilitated by the 
BioWare preparation module, which generates a sequence comparison report summary, based on 
pairwise alignment of etries in the data set. Entries having the same sequence (100%) identity 
were treated as duplicates. Duplicates of the same name and taxon (organism source) were 
compared; the entry judged to contain the most complete information was kept and the rest were 
deleted. Duplicates from different species were retained in the data set. Sequences having shared 
fragment or partial identity, where one sequence was an identical fragment of another, were 
checked for their uniqueness by referring to journals and cross-references field from the public 
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databases. Most of the entries that formed earlier versions of entries in the data set were also 
removed. All the deleted entries were added to the rejected file. The resultant data set was 
considered as the final data set. 
 
The cleaned, final data set is available on-line at http://sdmc.a-
star.i2r.org.sg/Templar/DB/snake_neurotoxin which was created using the BioWare-Templar 
module. In addition, protein 3-D structures were searched in the PDB databases. PDB structures 
were extracted and added to the svNTX database. Sequence entries and their corresponding 3-D 
structures were then manually linked.  
 
2.3 Data annotation 
Nearly 300 published journal articles and papers listed in the database were analysed for data 
enrichment with functional and structural enrichment. Six new fields containing information 
normally absent in public database entries were created for each entry. These fields are 
Action_site, Physiological_function, Critical_residues, Toxin_activity, Binding_affinity, and 
Miscellaneous. Action_site denotes the site of action of svNTXs. Physiological_function and 
Toxin_activity refer to published svNTXs function and LD50 values, respectively. 
Critical_residues reveal the critical amino acid residues that are involved in toxin-receptor 
interaction. Information from binding studies performed on svNTXs-receptor is represented by 
the Binding_affinity field. Miscellaneous field refers to other additional information relevant to 
functional or structural description of a svNTX. The description of data annotation is further 
discussed under results section. 
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2.4 Data analysis 
The svNTXs database was analysed to form a classification chart for the svNTXs based on 
structure and function. The disulfide bridge patterns, evolutionary relationships and 
pharmacological properties were used for the analysis. Sequence comparison of svNTX was 
carried out using CLUSTALW with the default parameters. From the multiple alignment 
analysis, it is evident that svNTXs contain highly conserved cysteine residues. Cysteine residues 
in a protein usually form a disulphide bridge with another specific cysteine residue. Classification 
of protein family based on cysteine pairing pattern has been used to classify scorpion toxins (Tan 
et al., 2001). It might be interesting to test this pairing pattern in svNTXs. The use of CysAlign 















                                        
 
 
                          
Search through each entry for information on disulphide bond 
Database in flat file format 
Plot disulphide bridge pattern for each entry 
that has disulphide bond information 
Group entries with similar disulphide bridge pattern 
Materials and Methods 
42 
2.5 Phylogenetic study 
Signal and leader sequences were removed and only mature, full length amino acid was used for 
phylogenetic studies. Phylogenetic studies were undertaken only for groups having more than 
four or more members for better statistical realiability. CLUSTAL-X (Thompson et al., 1997) 
was used for multiple alignment of amino acid sequences. The pairwise alignment parameters 
used were a gap opening penalty of 35 and a gap extension penalty of 0.75 whereas the multiple 
alignment parameters were a gap opening penalty of 15 and a gap extension penalty of 0.30.   
 
Each phylogenetic subgroup was generated by using the SEQBOOT program of PHYLIP 3.6a2 
(Felsenstein, 1985; 2001). Statistical reliability of the trees was assessed using 100 bootstrap 
replications. The bootstrap values of 90 and above are considered to be significant. The most 
parsimonious trees were calculated using the PROTPARS program using the maximum 
parsimony (MP) method (Saitou and Nei, 1987). MP method was chosen because this program 
takes into account the number of changes required at the nucleotide level to substitute one amino 
acid for another. In this scheme, the most accurate phylogenetic tree is one that is based in the 
fewest changes in the genetic code. The strict consensus trees were obtained using the 
CONSENSE program (Felsenstein, 2001). The rooted tree diagrams were generated with the 
TREEVIEW program (Page, 1996). Bee venom PLA2 (Swiss-Prot A59055) and Lynx1 (Swiss-
Prot AAF16899) were utilised as outgroups for analysis of presynaptic and postsynaptic NTXs 
subgroups, respectively.  
 
2.6 Bioinformatics tools used 
BioWare (Biological Data Warehousing) is a convenient, user-friendly tool for rapid building of 
data warehouses containing biological information. It contains different programs to retrieve raw 
data from diverse sources on the Internet, formulate and integrate this information into a central 
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repository and for rapid building of personal databases using a well-defined framework of the 
resultant database. This software is divided into three main modules which are used in the 
creation of svNTX database. 
 
1. BioWare-Retrieve obtains the required data from GenBank, Swiss-Prot and PDB sources. 
2. BioWare-preparation allows manual annotation of the data prior to creation of the 
database. 
3. Templar creates a personal searchable database as according to the specifications of the 
users on the uploaded data file. 
 
CysAlign facilitates in the grouping of entries in the database which share similar disulphide 
pattern, provided the pairing information is present in the entry. These groupings can be used to 
classify similar protein structurally. 
 
Clustal X, is a general purpose multiple alignment program for protein or DNA. BLAST (Basic 
Local Alignment Search Tool) is a local alignment program that uses a heuristic algorithm to 
detect relationships among sequences which share only isolated regions of similarity (Altschul et 
al., 1990). BLAST output assigns a statistical score to sequences similar to query sequence, 
making it easier to differentiate real and false hits. 
 
PHYLIP (the PHYLogeny Inference Package) is a set of modular programs used for inferring 
phylogenies based on evolutionary trees. It contains a broad variety of analytical methods such as 
parsimony, distance matrix, and likelihood methods. This program was used to build evolutionary 
trees in this project. 
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Section B: Experiment protocols 
 
2.7 Scorpion venom and venom glands 
The venom and venom glands of the Chinese scorpion, Buthus martensi Karsch were 
obtained from Wuhan University, China. 
 
2.8 Purification of scorpion venom 
Lyophilized crude venom (20 mg) was reconstituted in 2 ml water and separated on a gel 
flitration chromatography using Sephadex G50 column. Peak II of eluant was subjected to RP-
HPLC (Amersham) using a Jupiter C18 or C4 µBore column. The buffer systems used were 0.1% 
of trifluoroacetic acid (Buffer A) and 80% acetonitrile in 0.1% trifluroacetic acid (Buffer B). 
Flow rate was maintained at 1 ml/min. Individual fractions were collected, dried by speed vac, 
and reconstituted in 100 µl of water and subjected to gene expression studies. 
 
2.9 Purification of snake Bcntx-4 
Bungarus candidus crude venom (4 mg) was purified on RP-HPLC (SMART system, 
Pharmacia) using a Jupiter C4 column. The buffer systems used were 0.1% of trifluoroacetic 
acid (Buffer A) and 80% acetonitrile in 0.1% trifluroacetic acid (Buffer B). Flow rate was 
maintained at 1 ml/min. Individual fractions were collected, dried by speed vac, and reconstituted 
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2.10 Mass spectrometry determination and N-terminal amino acid sequencing 
The RP-HPLC purified proteins were subjected to N-terminal amino acid sequencing using a 
liquid-phase sequencer equipped with an on-line amino acid analyzer after analysis by  
matrix-assisted light desorption ionization mass spectrometry-time of flight (MALDI-TOF). 
 
2.11 Protein estimation 
Protein concentrations were determined by Bradford microassay procedure (Bradford, 1976) 
using Bio-Rad reagents. The samples were diluted 5 times and 1 ml of 5 times diluted dye 
concentrate reagent was added into the sample. After 15 minutes of incubation, the 
absorbance was read at 595 nm. A standard curve was drawn using bovine serum albumin 
(BSA) at concentrations ranging from 2 –10 µg/ml. 
 
2.12 Cell culture and medium 
Human neuroblastoma cells (ATCC number: CRL2270) were grown in DMEM medium 
supplemented with 10% fetal bovine serum, 50 units of penicillin, 50 µg/ml streptomycin.  
Cells were cultured in incubator using 5% CO2 and 95% air at 37°C.  
 
2.13 MTT cell viability assay 
MTT test is a colorimetric assay system which measures the reduction of 3-(4, 5-
dimetylthiazole-2-yl)-2, 5-diphenyl tetrazolium bromide; MTT) into an insoluble formazan 
product by activity of the mitochondrial enzymes in viable cells.  25 mg of MTT was 
dissolved in 50 ml of DMEM to a concentration of 0.5 mg/ml, filtered and stored in dark until 
use. A 96 well plate was seeded with 5000 cells per well and allowed to grow for 24 hrs to 
80% confluency at 37°C with 5% CO2. The cells were then treated with 600, 400, 200, 100, 
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50 µg/ml of BmKII fractions and incubated for 24 hrs. After incubation, the media was 
removed, cells washed twice with 1x saline and 60 µl MTT was added. MTT incubation was 
carried out for 1 hr. The medium was removed and the undissolved purple formazan crystals 
were solubilized in 250 µl of dimethylsulfoxide (DMSO).  Complete dissolution of crystals 
was achieved by shaking plates gently for 10 min at room temperature. Blanks were set up in 
wells that did not contain cells. Absorbance at 550 nm wavelength was measured 
spectrophotometrically. Viability of exposed cells was expressed as a percentage of untreated 
cells (100%). 
 
2.14 Microarray  
Neuroblastoma cells were treated with 35 µg/ml of BmKII fraction for 18 hrs. Total RNA 
was isolated according to protocol in section 2.25. RNA isolated was processed and 
hydridized to each array of the U133 GeneChip™ Array Set according to the protocols 
described in the GeneChip™ expression analysis technical manual (Affymetrix, Santa Clara, 
CA). Untreated sample was used as a negative control. Data from each treatment were scaled 
to an average intensity of 800. Relative mRNA expression levels were expressed as plus or 
minus fold changes compared with untreated control using Microarray Suite software 5.0 
(Affymetrix, Santa Clara, USA). All genes showing 4-fold or more were included in the 
subsequent analyses. Cluster members were classified according to their biological function 
as described in the NetAffy database (Affymetrix, Santa Clara, USA). 
 
2.15 Total RNA cleanup  
Total RNA (20 –50 µg) was cleaned up using RNeasy spin columns (QIAGEN) before 
microarray analysis. The final volume of total RNA is made up to 100 µl with sterile water. 
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RLT buffer (350 µl) was then added into the RNA and transferred into a spin column. The 
tube was spun for 2 min. Eluant was collected and spun again for 2 min. Eluant was 
discarded and 500 µl of RPE buffer was added in this washing step. Tube was spun again for 
2 min and waste discarded. The column was air dried until β-mercaptoethanol was not 
apparent. RNase-free water (15-30 µl) was added into column, waited for 1 min, followed by 
centrifugation for 2-3 min. The eluted RNA was quantitated  spectrophotometrically at 260 
and 280 nm. 
 
2.16 cDNA synthesis 
A total of 5 µg of cleaned RNA was used for first strand synthesis. 
2.16.1 Primer hybridization 
Reagents used in the first strand synthesis: 
Total RNA                                                5 µg 
T7-d(T) 24 primer (100 pmol/µl )               1 µl  
DEPC-H2O                                                       for final reaction volume of 20 µl  
The above reaction mix was incubated at 70°C for 10 min. Then, the tube was briefly pulsed 
and put on ice. 
  
2.16.2 Temperature adjustment 
The above reaction was then added into the following reagents and incubated at 37°C for 2 
min. 
5x first strand cDNA buffer                            4 µl  
100 mM DTT                                                  2 µl  
10 mM dNTP mix                                           1 µl  




2.16.3 First strand synthesis 
SuperScript II RT (1 µl) was added to the above tube and incubated at 37°C for 1 hr. The 
reaction was terminated on ice. The tube was centrifuged briefly to bring down condensation 
of water on the sides of the tube. 
 
2.17 Second strand cDNA synthesis 
The second strand synthesis was immediately carried out after the first strand synthesis. The 
following reagents were added to the first strand synthesis tube. 
DEPC-treated water                                         91 µl  
5x second strand reaction buffer                      30 µl  
10 mM dNTP mix                                             3 µl  
10 U/µl  E.coli DNA ligase                               1 µl  
10 U/µl  E.coli DNA polymerase I                   4 µl  
 2 U/µl  E.coli RNase H                                    1 µl  
    
The contents in the tube were gently tapped and briefly spun to remove condensation. Then, 
the reaction mixture was incubated at 16°C for 2 hrs in a cooling waterbath. Following 2 hrs 
incubation, 2 µl [10 U] of T4 DNA polymerase was added and incubated again at 16°C for 5 
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2.18 Cleanup of double stranded cDNA 
The clean-up was carried out in a two-step reaction. The first step involved the phase lock 
gels (PLG)-phenol/chloroform extraction and the final step involved ethanol precipitation. 
PLG form an inert, sealed barrier between the aqueous and organic phases of phenol-
chloroform extractions. The solid barrier allows more complete recovery of the sample 
(aqueous phase) and minimizes interface contamination of the sample. A standard 
phenol/chloroform extraction can be performed as an alternative to the PLG procedure. 
 
The PLG tube was briefly spun for 12, 000 x g for 20-30 sec. 162 µl  of 
phenol:chloroform:isoamyl alcohol in a 25:24:1 ratio saturated with 10 mM Tris-HCl pH 8.0, 
1 mM EDTA) was added to the final cDNA synthesis preparation. The tube was vortexed 
briefly. The entire 324 µl cDNA-phenol/chloroform mixture was added to the PLG tube. This 
suspension was centrifuged at 12,000 x g for 2 min. The upper aqueous phase was transferred 
to a fresh 1.5 ml tube. In the preceding step, 0.5 volumes of 7.5 N ammonium acetate and 2.5 
volumes of absolute ethanol were added to the sample and vortexed. The mixture was 
centrifuged at 12, 000 x g for 20 min. The supernatant was removed and the pellet was 
washed with 0.5 ml of 80% ethanol (stored at -20°C). The tube was then centrifuged at 12, 
000 x g at room temperature for 5 min. The 80% ethanol was carefully removed and the 80% 
ethanol step was repeated once again. The pellet was air-dried. The dried pellet was 
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2.19 Synthesis of biotin-labeled cRNA 
The RNA labeling transcript step is important for the production of large amounts of 
hybridizable biotin-labeled RNA targets by in vitro transcription from bacteriophage T7 RNA 
polymerase promoter. The use of T7 RNA polymerase and biotin-labeled nucleotides, large 
amounts of single-stranded nonradioactive RNA molecules can be produced during short 
incubation period. RNA-DNA hybrids have a higher melting temperature than corresponding 
DNA-DNA hybrids, therefore, single stranded RNA targets offer higher target avidity and 
greater sensitivity than DNA probes. The RNA targets offer selectivity unavailable with 
DNA targets – being single stranded, they are strand specific and hybridize more effectively 
to probes because the target population does not self-hybridize. Microchip array assays 
effectively used RNA transcripts that are labeled with biotin-modified ribonucleotides. The 
biotin labeled RNA targets that are hybridized to arrays of DNA probes can be detected by a 
reporter molecule linked to streptavidin, avidin or anti-biotin antibody. This type of complex 
can be detected directly by excitation of a fluorophore conjugated to streptavidin or indirectly 
by using an enzyme conjugate that can produce an insoluble colored precipitate. 
The following components were added to an RNase-free microfuge tube.  
 
Template DNA                                          1 µg of cDNA 
Distilled or deionised water                      to final reaction volume of 40 µl  
10x HY reaction buffer                             4 µl  
10x Biotin labeled ribonucleotides           4 µl  
10x DTT                                                   4 µl  
10x RNase inhibitor mix                          4 µl  
20x T7 RNA polymerase                         2 µl  
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The mixture was carefully mixed and collected at the bottom of the tube by a brief 
centrifugation. The tube was immediately placed in a 37°C waterbath. The tube was tapped 
gently every 30 – 40 min during the 4 – 5 hrs incubation. The end-product was stored at -
20°C. 
 
2.20 Cleaning up and quantifying in vitro transcription (IVT) products. 
The IVT cleanup reaction is essential to remove unincorporated NTPs. Only one-half of the 
IVT reaction was used for the cleanup. We employed RNeasy spin columns from QIAGEN 
as preferred method for IVT cleanup. The pure, eluted IVT product was quantitated using 
spectrophotometric analysis. For quantification of cRNA using total RNA as starting 
material, an adjusted cRNA yield was calculated to reflect carryover of unlabeled total RNA. 
Using an estimated 100% carryover, the following formula was used to determine adjusted 
cRNA yield. 
Adjusted cRNA yield = RNAm – (total RNAi) (y) 
RNAm = amount of cRNA measured after IVT (µg) 
Total RNAi = starting amount of total RNA (µg) 
y = fraction of cDNA reaction used in IVT 
The minimum concentration of purified cRNA must be 0.6 µg/µl before the cRNA can be 
fragmented for target preparation. 
 
2.21 Fragmentation of cRNA for target preparation 
The adjusted cRNA concentration was used in this reaction. The following components were 
added  to initiate the fragmentation reaction. 
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20 µg cRNA                                               1 – 32 µl  
5x fragmentation buffer                              8 µl  
RNase-free water                                           to 40 µl  
The final concentration of RNA in the fragmentation mixture can range from 0.5 µg/µl to 2 
µg/µl. The fragmentation buffer has been optimized to breakdown full length cRNA to 35 – 
200 bases fragments by metal-induced hydrolysis. The fragmentation mixture was incubated 
at 94°C for 35 min. Reaction was terminated on ice. The undiluted, fragmented sample RNA 
was kept at -20°C. 
 
2.22 Eukaryotic target hybridization 
In a hybridization cocktail for a single probe array, the following components were added: 
 Fragmented cRNA                                          15 µg 
Control oligonucleotide B2 (3 nM)                  5 µl  
20X Eukaryotic Hybridization Controls         15 µl  
Herring Sperm DNA (10 mg/ml)                     3 µl  
Acetylated BSA (50 mg/ml)                            3 µl  
2X hybridization buffer                                   150 µl  
H2O                                                                  to final volume of 300 µl  
 
The frozen stock of 20X GeneChip® Eukaryotic Hybridization Control cocktail was heated at 
65°C for 5 min to completely resuspend the cRNA before aliquoting. It contains bioB, bioC, 
bioD and cre prokaryotic enzymes. BioB, BioC and BioD are genes of the biotin synthesis 
pathway from the bacteria E.coli. cre is  the recombinase gene from P1 bacteriophage. These 
genes can be labeled and could served as hybridization controls when mixed with labeled 
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eukaryotic cRNA samples. The antisense strand of B. subtilis RNA controls are used for 
BioB, BioC and BioD genes. These controls can be spiked into samples during mRNA 
preparation to monitor the efficiency of target preparation, hybridization, washing and 
staining. The probe array was equilibrated to room temperature immediately before use. The 
hybridization cocktail was heated to 99°C for 5 min in a heat block.  
 
The probe array and a test array that were filled with 200 µl  1X hybridization buffer were 
incubated at 45°C for 10 min with rotation. The hybridization cocktail that has been heated at 
99°C was transferred to a 45°C heat block or 5 min. The cocktail was spun at a maximum 
speed in a microcentrifuge for 5 min to remove any insoluble material from the hybridization 
mixture. The buffer solution was removed from the probe array cartridge and filled with 250 
µl of the hybridization cocktail avoiding any insoluble matter in the solution at the bottom of 
the tube. Probe array was placed in a rotisserie box in a 45°C oven. The  
probe array was rotated at 60 rpm for 16hrs.  
 
2.23 Washing, staining and scanning 
After 16 hrs of hybridization, the hybridization cocktail was removed from the probe array 
and kept in a centrifuge tube. The probe array was filled with 200 µl of non-stringent wash 
buffer. We employed an antibody amplification wash and stain procedure. Streptavidin 
phycoerythrin (SAPE) staining reagent was prepared. SAPE was stored in the dark at 4°C. It 
should not be frozen. The tube was tapped to mix well before preparation of any stain 
solution. The SAPE stain solution should be prepared immediately before use. 
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For each probe array to be stained, the following components were combined in a 
microcentrifuge tube: 
2X MES stain buffer                                                 600 µl   
50 mg/ml acetylated BSA                                         48 µl   
1 mg/ml SAPE                                                          12  µl   
distilled water                                                            540 µl   
The SAPE solution is mixed well and divided into two aliquots of 600 µl each to be used for 
first and third staining respectively. An antibody mixture was prepared with the following 
reagents. 
2X MES Stain buffer                                                300.0 µl  
50 mg/ml acetylated BSA                                         24.0 µl  
10 mg/ml normal goat IgG                                       6.0 µl  
0.5 mg/ml biotinylated antibody                              3.6 µl  
distilled water                                                           266.4 µl  
 
A fluidics protocol was used to test the array chip and test chip. 80 µl of hybridization buffer 
was added into the test chip and the following steps were used to test the quality of reagents. 
Post Hyb Wash #1       10 cycles of 2 mixes/cycle with wash buffer A at 25°C  
Post Hyb Wash #2         8 cycles of 15 mixes/cycle with wash buffer B at 50°C 
Stain                              The test probe was stained for 10 minutes in SAPE solution at 25°C 
Post stain wash             10 cycles of  4 mixes/cycle with wash buffer A at 30°C 
2nd stain                         The probe array was stained for 10 min in the antibody solution at 25°C 
3rd stain                          The probe array was stained for 10 min in SAPE solution at 25°C 
Final Wash                    15 cycles of 4 mixes/ cycle with wash buffer A at 35°C.     
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                                      Temperature was held at 25°C.  
 
At the end of this wash, 80 µl of hybridization buffer was removed from the test chip and 
mixed back into the rest of  220 µl  hybridization buffer. The 300 µl of hybridization buffer 
was injected into the probe array chip and the following steps were performed in the fluidics 
station. 
Post Hyb Wash #1        10 cycles of 2 mixes/cycle with wash buffer A at 25°C                        
Post Hyb Wash #2        4 cycles of 15 mixes/cycle with wash buffer B at 50°C 
Stain                              The probe array was stained for 10 minutes in SAPE solution at 25°C 
Post stain wash             10 cycles of  4 mixes/cycle with wash buffer A at 25°C 
2nd stain                         The probe array was stained for 10 min in antibody solution at 25°C 
3rd stain                          The probe array was stained for 10 min in SAPE solution at 25°C 
Final wash                     15 cycles of 4 mixes/cycle with wash buffer A at 30°C.  The final  
                                       holding temperature is 25°C. 
The above fluidics protocol was selected and ran using the GeneChip® Fluidics Station 400. 
At the end of the wash protocol, the probe array was scanned by Affymetrix® Microarray 
Suite. The laser was warmed up prior to scanning by turning the laser at least 15 min before 
use. Probe array that was stored at 4°C had to be warmed up to room temperature before 
scanning. After scanning the probe array, the resulting image data created was stored on the 
hard drive of the GeneChip® Analysis Suite/ Microarray Suite workstation as a .dat file with 
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2.24 Microarray data analysis 
In the first step of the analysis, a grid was automatically placed over the .dat file demarcating 
each probe cell. One of the probe array library files, the .cif file was used by Microarray Suite 
to determine the appropriate grid size used. The alignment of the grid was confirmed by 
zooming in on each of the four corners and on the center of the image. If the grid was not 
aligned properly, the alignment was adjusted by placing the cursor on an outside edge or 
corner of the grid. The cursor image will be changed to a small double-headed arrow. The 
grid will then be adjusted using the arrow keys on the keyboard or by clicking and dragging 
the borders with a mouse.  
Affymetrix® Microarray Suite was employed to analyze hybridization intensity data from 
GeneChip® expression probe arrays. This software calculates a set of metrics that describe 
probe set performance. The gene expression levels from treated and untreated samples were 
compared using a comparison expression analysis that is available in the software to calculate 
a set of comparison metrics. Some of the metrics which were used by a decision matrix to 
determine a Difference Call for each transcript: Increased (I), Decreased (D), Marginally 
Increased (MI), Marginally Decreased (MD) or No change (NC). In our microarray 
experiment, we only took into consideration I and D transcript level call for further analysis.  
A “fold change” calculation was also computed to indicate the relative change of each 
transcript represented on the probe array. Only those set of genes having 4 fold change in 
their expression level were included for further functional annotation. The detailed steps for 
running the software is available on the Microarray Suite User’s Guide (Affymetrix, Santa 
Clara, USA).  
 
 
Materials and Methods 
57 
 
2.25 Isolation of total RNA 
Total RNA was isolated by a single-step method using TRIZOL® (Invitrogen). The total 
RNA was treated with RNase-free DNase I at 37°C for 20 min and kept at -70°C until further 
use. The concentration and purity of RNA was then estimated spectrophotometrically at 260 
nm and 280 nm. The intregrity of RNA was analysed using 1% denaturing formaldehyde gel 
elelectrophoresis. 
 
2.26 RNA gel electrophoresis  
Denaturing agarose-formaldehyde gel electrophoresis was used for the size fractionation of 
RNA (Lehrach et al., 1977). Container or gel tank in contact with RNA samples were swiped 
in 70% ethanol. A 1% (w/v) agarose-formaldehyde was prepared by melting 0.5 g of agarose 
in 43.5 ml of autoclaved water and cooled to 60°C. 5 ml of 10x MOPS, 1 ml of 37% 
formaldehyde and 1 µl of 10 mg/ml of ethidium bromide were added and casting of the gel 
was carried out in fume hood. RNA sample was prepared as follows: 
RNA (0.5 µg – 10 µg)                           4.5 µl  
10x MOPS buffer                                 2.0 µl  
Formaldehyde (pH>4.0, 37%)             3.5 µl  
Deionized formamide                          10.0 µl  
RNA loading buffer                             3.5 µl  
The sample was mixed and heated to 60°C for 10 min prior to loading and electrophoresis 
was carried out in 1x MOPS buffer. RNA bands were visualized under UV-light after 
electrophoresis. The image was recorded, captured and saved using a gel documentation 
system (Bio-Rad, USA). 
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Gene Primers sequences Tm Amplicon Size
Aldehyde dehydrogenase Fwd : 5' GCAGTGAAGGCCGCAAGA 3'    58 70 bp
Rev: 5' CCCTCTCGGAAGCATCCATA 3' 60
Amphiregulin Fwd: 5' ACTCGGCTCAGGCCATTATG 3' 62 68 bp 
Rev: 5' ATGGTTCACGCTTCCCAGAGTA 3' 66
Annexin A2 Fwd: 5' GTGCATATGGGTCTGTCAAAGC 3' 66 72 bp 
Rev: 5' TGGCTGTTTCAATGTTCAAAGC  3' 62
Calponin 3 Fwd: 5' ACATTACAGCCGGTGGACAAC 3' 64 72 bp
Rev: 5' TCCTTTCTGGGAAGCAACTTTG 3' 64
Cysteine rich protein 1 Fwd: 5' CCAAGTGCAACAAGGAGGTGTA 3' 66 92bp 
Rev: 5' CCCACATTTCTCGCACTTCA 3' 60
Fibroblast growth factor 2 Fwd: 5' AGCGACCCTCACATCAAGCT 3' 62 77 bp
Rev: 5' CGGTTAGCACACACTCCTTTGATA 3 70
GABA(A) alpha 5 receptor Fwd: 5' CCCCAGACACGTTCTTCCA 3' 60 64 bp 
Rev: 5' TTGTTGGGCGTGGTCATGT 3' 58
Galanin Fwd: 5' GAACAGCGCGGGCTACCT 3' 60 71 bp
Rev: 5' GGCCATTCTTGTCGCTGAA 3' 58
KRIT2 Fwd: 5' GGAATGCGTCTCTCTCAAGAAAC 3' 68 117 bp
Rev: 5' TGGCCAGTCACGAACATGTT 3' 60
Neuregulin 1 Fwd: 5' TGTGCAAGTGCCCAAATGAG 3' 60 68 bp 
Rev: 5' ACTGTAGAAGCTGGCCATTACGT 3' 68  
2.27 Real-time quantitative PCR  
Gene specific PCR primers were designed using the PrimerExpress 2.0 (Applied Biosystems, 
USA) according to their corresponding mRNA sequences. The primers were designed to 
yield amplicons of less than 100 base pairs and synthesized by Alpha DNA USA). 18S 
ribosomal RNA was used as an internal calibrator. The primer sequences for the ten genes 












Table 2.1: Primer sequences used for real-time PCR. Primers were designed using 
PrimerExpress 2.0 software (Applied Biosystems, USA).  
A two-step reaction was used in this study. For each reverse transcription (RT) reaction, the 
following reagents composition was used. 
    
10x PCR Buffer                                                                                   1.0  µl        
 MgCl2 (25 mM)                                                                                  2.2 µl  
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 dNTPs (25 mM each of dATP, dCTP, dGTP and dUTP)                  2.0 µl        
 Random hexamers (224 µM)                                                              0.6 µl  
 RNase inhibitor (20 U/λ)                                                                    0.2 µl                                                      
 Reverse transcriptase (50 U/λ)                                                           0.3 µl  
 DEPC H2O                                                                                         2.76 µl  
      
A total of 12 µl of RT reaction mixture and 3 µl of total RNA (100 ng/µl) was used to carried out 
RT  reaction. RT reaction was carried out as: 25°C/ 10”, 37°C/ 60” and 95°C/ 5”.  
PCR was then performed on the RT products. For each PCR reaction, the following reagents 
were used: 
SYBR® green mix                                                                               25 µl                  
Sense primer (100 nM)                                                                        x  µl                             
Anti-sense primer (100 nM)                                                                 y µl  
Sterile water                                                                                     14.8 µl  
 
The PCR amplification was then performed at 50°C for 2 min and 95°C for 10 min per cycle 
for 40 cycles with each cycle at 94°C for 15 sec and 60°C for 1 min. All reactions were 
carried out in triplicate using the ABI Prism 7000 SDS (Applied Biosystems, USA). 
 
2.28 Purification of Torpedo californica acetylcholine receptors 
Preparation of nicotinic acetylcholine receptor from Torpedo californica was carried out 
according to the procedure described by Ishikawa et al. (1977) with some modifications. 10 g 
of frozen tissue was defrosted and cut into small pieces. The tissue was homogenized with 20 
ml distilled water for 4 min with 3 interval time in a warring blender in ice-cold vessel. The 
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suspension was then again homogenized in IKA-Werk homogenizer (200 rpm) followed by 
low speed centrifugation at 3000 x g for 10 min at 4°C. The supernatant was centrifuged at 
10, 000 x g for 20 min at 4°C. The pellet was resuspended in 8 ml of Tris buffer and 
homogenized with natural homogenizer. The homogenate was spun as above and the pellet 
was resuspended in 5 ml of Tris buffer and centrifuged as above. The pellet then was 
resuspended in Tris buffer to the concentration of 1 mg/ml, aliquoted in eppendorf tubes and 
kept at -70°C. The whole procedure was done at 4°C.  
  
2.29 Competitive binding assay 
Competitive binding assay were performed using nAChR. Increasing concentrations of 
unlabelled Bc-ntx4 was added to a single concentration of 5 nM 125I-α-Bgt to study their 
inhibitory effect on  high affinity toxin binding. 2.5 µg of Torpedo membrane was incubated with 
125I-α-Bgt at room temperature for 1 hr in presence of increasing concentrations of competitors in 
the total volume of 200 µl. Reaction was terminated on ice and the membranes were recovered by 
centrifugation at 10, 000 x g for 5 min. Membranes were was washed with 1 ml of Tris buffer 
supplemented with 0.1% bovine serum albumin (BSA) and dried before subjecting to radioactive 
monitoring in a COBRA Auto Gamma Counter (Parkard Instrument Company, USA). 
 
2.30 Statistical analysis 
Statistical analyses were performed using unpaired Student’s t test and results were expressed 
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Section C List of chemicals used: 
Chemical and solvents are all of analytical reagent grade obtained mainly through National 
University Medical Institutes (NUMI) laboratory from the following suppliers: 
 
Sigma Chemicals Co., St. Louis, MO, USA 
Bovine serum albumin (BSA), formamide, L-glutamine, MOPS (3,-(N-Morpholino) 
propanesulfonic acid), DMEM basal medium, MES free acid monohydrate, MES sodium salt, 
EDTA disodium salt (0.5 M solution), Tween-20.  
Sigma-Aldrich 
Goat IgG, anti-streptavidin antibody (goat), MTT  
Gibco-BRL Gaitherssburg, MD, USA 
Agarose, fetal bovine serum 
Pharmacia 








SYBR® Green PCR Master Mix, TaqMan® RT Master Mix. 
Invitrogen Life Technologies 
Trizol® Reagant, Acetylated bovine serum albumin (BSA) solution (50 mg/ml) 
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Promega Corporation 
Herring sperm DNA 
 
Affymetrix, Santa Clara, CA, USA 
Human genome gene chip U133 Plus 2.0 Array, GeneChip® Eukaryotic Hybridization Control 




Solutions and buffers 
2.32 Reagents for PR-HPLC 
2.32.1 Buffer A: 
Trifluoroacetic acid (TFA, HPLC grade)                                     0.1% (v/v) 
2.32.2 Buffer B: 
Acetonitrile (HPLC grade)                                                           80% (v/v) 
Trifluoroacetic acid (TFA, HPLC grade)                                     0.1% (v/v) 
 
2.33 Buffers for RNA clean-up 
2.33.1 RLT buffer 
Commercially available from QIAGEN. Contains guanidine thiocyanate. 10 µl of 14.3 M of 
β-mercaptoethanol was added to 1 ml of RLT buffer. This mixture was found to be stable for 
a month. 
 
2.33.2 RPE buffer 
Commercially available from QIAGEN.  
 
2.34 Buffers for cRNA target hybridization 
2.34.1  12X MES stock  
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MES free acid monohydrate                                               1.2 M    
MES sodium salt                                                                         0.89 M 
The reagents was mixed throughly and adjusted to final volume of 1000 ml of autoclaved 
water. The solution (pH between 6.5 – 6.7) was filtered through a 0.2 µm filter. Solution was 
stored at 4°C and shielded from light. The solution was discarded if colour turned yellowish. 
 
2.34.2 2X hybridization buffer  
12X MES Stock                                               0.1 M 
5 M NaCl                                                                                     1M 
0.5 M EDTA                                                                                0.02 M 
  10% Tween 20                                                                              0.1% (v/v)   
 
The final volume of buffer was adjusted to 50 ml of autoclaved water. It was stored at 4°C 
and shielded from light. 
      
       
2.35 Buffers for array processing, washing and staining 
 
2.35.1 Non-stringent Wash Buffer (Wash Buffer A) 
 
NaCl                                                                                            0.9 M 
NaH2PO4                                                                                     0.06 M 
EDTA                                                                                          0.006 M                                              
  10% Tween-20                                                                             0.01 % (v/v) 
 
The final buffer volume was adjusted to 1000 ml of water and was filtered through a 0.2 µm 
filter and stored at 4°C. 
 
2.35.2 Stringent Wash Buffer (Wash Buffer B) 
 
12X MES Stock Buffer                                                           0.1 M 
NaCl                                                                                        0.1 M 
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Tween 20                                                                                 0.01 % (v/v)  
The final buffer volume was adjusted to 1000 ml of water and filtered through a 0.2 µm filter 
and stored at 4°C. 
 
2.35.3 2X stain buffer  
 
12X MES stock buffer                                                               0.1 M 
NaCl                                                                                           1 M 
Tween 20                                                                                    0.05 % (v/v)   
 
The final volume of buffer was adjusted to 250 ml of water and filtered through a 0.2 µm 
filter. Solution was stored at 4°C and shielded from light. 
 
2.35.4 10 mg/ml Goat IgG Stock 
The antibody stock was resuspended in 5 ml PBS and stored at 4°C.  
     
2.35.5 20X SSPE buffer 
 
NaCl                                                                                         3 M 
NaH2PO4                                                                                  0.2 M 
EDTA                                                                                       0.02 M 
 
2.36 10X Phosphate-buffered saline (PBS) 
 
NaCl                                                                                         0.2 M                                                            
KCl                                                                                         0.0027 M 
Na2HPO4                                                                                              0.0081 M 
KH2PO4                                                                                  0.00176 M 
The above reagents were weighted and added into 800 ml distilled water. The pH was 
adjusted to 7.4 with HCl and topped up with H2O until a final volume of 1000 ml. Stock PBS 
solution was autoclaved and stored at room temperature. 
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2.37 Reagents for RNA gel electrophoresis 
         
2.37.1 Ethidium bromide 
Ethidium bromide was dissolved in water at 10 mg/ml concentration and stored in a light-tight 
bottle. The final working concentration was 0.1 µg/ml. 
 
2.37.2 10x MOPS running buffer 
Morpholinopropanesulphonic acid (MOPS), pH 7                      0.4 M 
Sodium acetate                                                                             0.1 M 
EDTA (pH 8)                                                                               0.01 M 
The above solution was adjusted pH7 and topped up to a final volume of 1000 ml. 
 
2.73.3 DEPC-treated water 
Diethyl pyrocarbonate (DEPC)                                                    0.2 % (v/v) 
DEPC was added to 100 ml of deionised water and shaken vigorously to mix. It was incubated at 
37°C for 1 hr and autoclaved to inactivate the DEPC. The solution was stored at room 
temperature.  
 
2.37.4 Deionized formamide  
Formamide (550 ml) was added to 500 mg Dowex XG8 mixed bed resin for 1h, followed by 
filtration through Whatman No.1 paper. Deionized formamide was stored at -20°C. 
 
2.37.5 RNA loading buffer 
Glycerol                                                                                 50% (v/v) 
EDTA (pH 8)                                                                         1 mM 
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Bromophenol blue                                                                 0.4% (w/v) 
The above reagents were made up to 10 ml of water and stored at room temperature. 
 
2.37.6 Formaldehdye 
Formaldehdye (37% v/v) was prepared and stored in a light-tight container at room temperature. 
 
2.38 Buffer for real-time PCR 
2.38.1 10x PCR buffer 
Tris-HCl (pH 8.3)                                                                    0.1 M 
KCl                                                                                          0.5 M 
Gelatin                                                                                     0.01% (v/v) 
 
2.39 Buffer for receptor binding studies 
2.39.1 Krebs-Ringer HEPES (KRH) buffer, pH 7.4 
NaCl                                                                                        0.128 M 
KCl                                                              0.005 M 
CaCl2                                         0.0027 M 
MgSO4                   0.0012 M 
Na2HPO4       0.001 M 
Glucose                  0.01 mM 
HEPES                   0.02 mM 
 























The most serious effects of snake envenomation are due to neurotoxins (NTXs). For example, 
the most toxic component in cobra venom is the postsynaptic neurotoxins with an LD50 (i.v.) 
of 0.05 – 0.2 µg/g of mouse (Tan, 1983). Toxin entries in public DNA and protein databases 
represent only a tiny fraction of less than 1% of the estimated natural library (Tan et al., 2003). 
Because of growing number of identified svNTX sequences, it is increasingly difficult to study 
them by experimentation alone. Detailed bioinformatics analysis offers a convenient 
methodology for efficient in silico preliminary analysis of possible function of new toxins. The 
in silico approach can assist in designing experiments for functional characterization of the 
newly identified svNTX sequences, particularly those identified as novel cDNAs.  
 
A bioinformatics approach was utilized in the construction of a svNTXs database. This chapter 
focuses on the compilation and consolidation of svNTXs data, which were stored in a newly 
created, specialized database. The entries in svNTXdB have been classified and annotated to 
enhance new knowledge discovery. It also had a set of tools including structure-function 
prediction module. Our primary objectives were to facilitate information retrieval and data 
analysis of enriched and unique compilation of svNTXs extracted from public databases and 
published reports. Each database entry is then hyperlinked to an external database such as 
NCBI, SwissProt or EMBL.  
 
3.2 Data acquisition  
 
As of April 2003, the svNTXs database contains 272 unique entries of neurotoxin. A 
preliminary search using BioWare retrieval software with the keyword “Serpentes and 
Neurotoxin” returned 821 entries on svNTXs. Serpentes keyword was included in the search as 
it much more representative of all snake species and together with neurotoxin word in the 
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search, entries that had both terms were extracted. These 821 entries were the initial data set. 
Depending on their function, various databases carry a wide range of format. We merged the initial 
dataset into a BioWare integrated format. Preliminary filtering was carried out to remove non-
snake neurotoxins and replicate entries. Ultimately, 272 entries remained in the dataset, which are 
unique. This entry was referred to as the final data set. The breakdown of the each entry was listed 
in Table 3.1. Four entries were found only in the published journal. These were listed in Table 3.2. 
 
The majority of the entries in the final data set were mainly complete mature peptides with the 
signal peptide. Out of 272 entries, 260 neurotoxins had the complete mature peptide and 12 were 
incomplete. Only 99 neurotoxins out of 272 entries had the signal peptide sequence. The summary 
























Table 3.2: Sequence identity for the four unique toxins that are not found in public databases 





Table 3.3:  Number of the complete, incomplete and missing sequences in the snake 
venom neurotoxins in the final data set. 
 
3.3  Database features 
Snake NTX had five major search or extraction tools: BLAST search, Query svNTX, Structure 
viewer, Download FASTA and Annotate svNTX. BLAST search allows user to perform a 
sequence similarity search against snake NTX database (Altschul et al., 1997). Users can 
specify output alignment result in either standard BLAST output or color-coded multiple 
sequence alignment generated using Mview program (Brown et al., 1998). The Query svNTX 
feature allows users to search entries in the database by simple keywords such as Naja, 
bungarotoxin, or ion channel toxin. The search results are displayed in a tabular form as a list 
containing accession numbers, species and toxin name. Each match in the result output is 
hyperlinked to the full data record. Structure viewer feature (requires Internet Explorer 6.0 or 
Netscape 4.75) consists of three-dimensional (3-D) structures of snake venom NTXs that are 
extracted from PDB. This simple feature allows users to view available 3-D file using Chime 
viewer or download PDB files of user-specified records. Annotate svNTX is a simple 
prediction module tool which allows user to predict function of an unknown svNTX. Users can 
T o x in S e q u e n c e R e fe re n c e s
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S R C R R P S E T C
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Sequence Signal peptide Mature
Complete 99 260
Incomplete 11 12
Missing 162  - 
Total 272 272  
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also choose to download FASTA formatted files of amino acid from the database under the 
option Download FASTA.  
 
Figure 3.1 shows the typical outlay of the svNTXs homepage. The five major extraction tools 





















Figure 3.1: The user interface of the svNTXs database. Description of the five major tools 




































Figure 3.2: An output feature of the search (partial) using the keyword “Bungarotoxin”. 














3.4 Descriptions of the svNTX individual record 
Each NTX entry in the database is stored as an individual record. A representative record in 







































Figure 3.3: An example of an outlay of record available in the database. The individual 






found mostly in each entry. Complete entries have additional fields for structural and 
functional information. 
Each NTX entry in the database was given a unique accession number ‘DBACC’ in the form 
of [D][six digit number], where the six digit number was the unique descriptor for each record. 
‘Date’ field indicates the date when the entry was made.  
 
‘Name’ field contains the name of the toxin used in published journal and in public databases. 
The ‘Accession’ field provides hyperlinks to corresponding entries of the relevant databases 
such as GenBank, Swiss-Prot or EMBL where the original sequence was deposited. The 
organism source of each toxin and its taxonomical classification can be found in the ‘Source’ 
and ‘Species’ fields respectively.  
 
Functional information based on experimental studies from various reports had been included 
to enhance unique features of the database. These were represented by six fields known as 
‘Action_site’, ‘Physiological_function’, ‘Critical_residues’, ‘Toxin_activity’, 
‘Binding_affinity’ and ‘Miscellaneous’. The ‘Binding_affinity’ and ‘Critical_residues’ 
fields are unique in our database and not available in any public domain.  
 
The ‘Action_site’ field indicates the site of action in which the NTX acts either 
presynaptically or postsynaptically. A brief description of the NTX function is denoted by the 
field ‘Physiological_function’. ‘Toxin_activity’ fields refer to the toxicity in terms of LD50 
values. ‘Binding_affinity’ fields refer to the toxin-receptor interaction in terms of Kd or IC50 
values. The critical amino acid residues involved in receptor binding and other miscellaneous 
comments are provided in the ‘Critical Residues’ and ‘Miscellaneous’ fields respectively. 
Each record has its corresponding reference(s) listed.  
 
Structural features of the toxin, such as residues forming the disulfide bridges are described in 
the field ‘Features’. Putative structural information derived by similarity to known structures 
by amino acid alignment is indicated as ‘BY SIMILARITY’. A ‘svNTXdB’ sign followed by 
‘BY SIMILARITY’ field implies data added by the authors which was not available in the 
public databases. In addition any ‘Conflict’ field list down the amino acid discrepancies 
between records of a particular NTX in different databases or published journal. The field 
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‘Translation’ provides the amino acid sequence of the toxin. ‘Structure’ field contain 
internal hyperlink to the PDB structure stored in the database, subjected to the availability of 
the 3-D structures.  
 
The ‘Reference’ field consists of a list of literature references, with author names and journal 
titles. Some reference entries have the sign ‘svNTXdB’ which denotes publications that have 
been added by us which are not listed in any public databases.  
 
The svNTX database was largely compiled from public databases, which are unfortunately 
prone to errors. Common errors that are encountered as summarized in Figure 3.4. For 
example, entries Q9PSN6, Q91138 and Q91139 in the public database show the origin of these 
toxins from Naja naja (Indian cobra) when the correct species should be Naja sputatrix 
(Malayan cobra). Other common errors from these sources were different names for similar 
toxin and different sequence for similar toxins. Although Swiss-Prot typically provides lethal 
dose (LD50) values, one particular entry - long NTX OH-5 (P80965) - did not have this 
information although its LD50 is available in the original paper. These errors were reduced by 

























3.5 Classification of snake venom neurotoxins 
 
svNTX data was analysed to form a classification system for prediction of their structure and 
function. Properties such as cysteine pairing patterns, phylogenetic relationships, and detailed 
functional and structural classification were considered in order to build a classification chart. 
Initially, cysteine pairing pattern was analysed as this method has been shown to accurately 
classify the members of scorpion toxin families (Tan et al., 2003). However, the result was 
inconclusive as distinct structure-function relationship could not be observed for each 
disulphide bridging pattern. Although 12 unique disulfide pairing patterns were observed, we 
could not correlate any significant structure-function relationship because multiple functional 
groups were observed in one individual disulphide group (Figure 3.5). For example, 
fasciculins (acts presynaptically and inhibiting acetylcholinesterase) and short-chain 
neurotoxins (acts postsynaptically and binds to nAChR) in cysteine pairing group 1 (Table 3.4) 
share similar disulfide pairing pattern but exhibit very different pharmacological functions. 
Hence, disulfide pairing pattern cannot be used as an indicator for structure-function prediction 
in snake neurotoxins. 
 
One of the more commonly used bioinformatics method for analyzing venom-toxin data is 
phylogenetic analysis (see Tan et al., 2003). This method had been employed to determine 
diversification of conotoxins and classification of scorpion and snake toxins (Tytgat et al., 
1999; Espiritu et al., 2001; Okuda et al., 2001; Tsai et al., 2002; Fry et al., 2003). However, 
phylogenetic groups alone did not correlate well to functional groups of svNTXs. Therefore, 
we decided to classify svNTXs by combining pharmacological function and phylogenetic 
studies. Phylogeny was determined using maximum parsimony (MP) method to test whether a 
direct structure-function prediction can be deduced. Members in a clade having a bootstrap 
value of 90 are grouped together. Groups having 5 or more members will only be considered 
for phylogenetic analysis. Detailed pharmacological functional data such as site of action and 
molecular targets of the svNTXs was used based on annotations available in the database. We 
combined the functional annotation with the MP method to define structure-function 
classifications. The database currently contains data of 260 full length svNTXs that have well-
defined pharmacological functions. 53 (20.4%) proteins belong to the presynaptic NTXs 
group, 155 (59.6%) proteins belong to the postsynaptic NTXs, 3 (1.2%) have both pre and 
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postsynaptic effect, and 49 (18.8%) have other functional properties. Those classified as 
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Figure 3.5: Unique disulfide pairing patterns of all the neurotoxins. The C represent the 
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Table 3.4: The distinct disulfide pairing pattern of mature svNTXs. Functional grouping 
could not be observed using this method. For example, fasciculin (P01403) and short 
neurotoxins in Group A share similar disulfide pairing pattern but different pharmacological 





Groups Ent r i es
A O57327 P25675 P01431 Q9YGX0 P01421 W-IV Q9PUB7 P01412 P83346  Q9DE57
BAC78199  P25495  P01420  P14613 P01425  P43445 Q9YGX1  P25497  P01422 P01416
P01403  P10808 Q9W717  P59275 P01414 P25493 S48648  P80494 Q91139  Q9YGI8
P01432 Q9PRJ7 Q8UW26  P01430  P82464  N1NJ2P P01435 P01429 AAB50805  P82849
P01415 P01428 P01423 P32879 P80495  P01433  P25681 P01426 Q9YGC7 Q9PRJ5
Q9YGJ5 P19959  Q9PRJ3  O57326 Q8UW27 P80548  Q91138 Q9YGC4 Q9YHV0 Q9PSN6
Q9W7J7 P01424 AAB36087 Q9YHU9 P10460 P25492 P19958 Q9YGW9 P34076 P01418
P25683 Q9PRJ6 A27580 AAM00185  P01437 P25676 P01434  Q9W7K1 Q9W727 W-III
Q9W7K0  P83302 CAB43097 Q9PRJ0 Q9W7K2 Q9YGI0 0901189B Q9W7J6  671059A Q9YGC2
 Q9DEQ3  Q90VW1 P59276 AAD40971  P19960 P01438 P18328 Q9PWJ4  Q9YGJ6  P80958
0901189A P25494 P10458 Q9YGW8 P01417  P81030 Q9PRI1 P34075  P14534 P25496
Q9W7J9  P01427 S14003  P82462
B P01384  P01395  P14612 Q9W726  P13495 O12962 AAC83981 P82662 P01389  AAC83997
P25670 P01383 AAC83996  P01393 Q8UW28 O42257 P01391 AAC83987  BAA32992 P15815
P15817 P01379 P07526 P01385 Q9W7J5 AAC83990  Q9W729 CAA72434 P01386 P01398
P80965 AAC83982 P01390 P01381  P80156 P01382 P25674  P01397  P25671 P01380
764177A  P34073 O12961 AAC83985 P01388  P25667  P01394 P01387  CAB51841 P01396
AAC83986  P25672  P25668 Q8UW29 AAC83995 Q9W797  P15816 P25673
C CAA06886 P01401 Q9W796  P01400  O12963 O42256 P15818 Q9YGI7 P01399 O93422
P81783 Q9W7I3 P25680  P81782 Q9YGI2 P58370 P29180 CAD18848 P29179 P82935
P29182 Q9YGI1  Q9W7I4 Q9YGJ0  P29181 P25679 Q9YGH9 O42255
D PSKFAU Q8AXW2 Q8QFW3 P59018 Q9PTA5 P00617 Q9PU97 Q8QFW4 P00618 PSKF3U
AAB36096 Q8AXW0 P00619 Q9PTA7 P17934 Q90251 Q9PTA6
E P10116  Q8UUI0 P00628 P00614 P20259 P00610 P23026 P00629  Q8UUH9 Q8UUH7
P00608 Q9DF52 P20258 Q9PSN5 Q8UUH8  P00609
F P00979 P00982 P00981 P00980








The classification trees of the full length svNTXs was depicted in Figure 3.6. This classification 
system was broken into six layers. Layer 1 depicts the NTX site of action; layers 2 and 3 represent 
functional and structural properties of NTXs respectively; layer 4 denotes the molecular target of 
each svNTX, and layer 5 represents the subclassification of NTX based on phylogeny relationship. 
The final layer represents group labels. Presynaptic NTXs exhibit at least eight different functions 
(Figure 3.6, layer 2), and can be classified into five major groups: 1) NTXs that inhibit 
acetylcholine release; 2) NTXs that facilitate acetylcholine release either by blocking voltage gated 
potassium channel or some unknown mechanism; 3) NTXs that inhibit acetylcholinesterase and 4) 
NTXs that block calcium channel; and 5) NTXs that exhibit multiple functions such as 
myotoxicity, hemorraghic/hypotensive or bactericidal activity. 
 
 
Group 1 neurotoxins had two distinct groups, those possessing inter disulfide (S-S) chains and 
those without. The molecular target of these neurotoxins is the phospholipid membrane. The 
group 1 of svNTXs formed six phylogenetic subgroups (Figure 3.6; layer 6). Toxins in groups 
1-A1, 1-A2, 1B-3 and 1B-4 originate from the Elapidae snake family and groups 1B-1and 1B-
2 were from Viperidae family toxins. 
 
Several interesting features can be observed from Figure 3.6. Phospholipase A2 KPA2 
(Q9DF52) from Bungarus caeruleus and phospholipase A2 He (Q9PSN5) from Notechis 
scutatus scutatus in group 1B-4 exhibit additional function such as anticoagulant or myotoxic 
activities. However, three other members (P00628, P00629, P00616) from this group do not 
show anticoagulant activity. This could suggest that, based on evidence from phylogenetic 
analysis, these three svNTXs could possibly have anticoagulant/myotoxic activity that is yet to 
be determined. One svNTX from group 1B-2 (F15; Toyama et al., 2003) and two svNTXs 
from group 1B-3 (P00608 and P00610) also demonstrated additional functional properties 
besides neurotoxicity (Figure 3.6; Table 3.5). Some of the functions were myotoxicity, 
hemorrhagic and bactericidal activities. It may be possible that other neuoroxins members in 
these groups possess multiple function(s) as well. 
 
 
Groups 2A1-3 of presynaptic neurotoxins from Dendroaspis facilitate acetylcholine release 
and block voltage-gated potassium channel (Harvey and Anderson, 1991). Group 2B was 
found to be a unique group – it is the only three-finger neurotoxin reported to date to act 
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presynaptically to facilitate acetylcholine release (Kuhn et al., 2000). Group 3 consisted of 
presynaptic neurotoxins that inhibit acetylcholinesterase activity. Acetylcholinesterase-type 
NTXs had so far been isolated from African mambas (Dendroaspis) and are cross-linked by 
four disulfide bonds. 
 
Group 4 consisted of only one member, lethal peptide I (P24335) which contained only 1 
disulfide bond and found to block calcium channels at the presynaptic membrane (Aiken, 
1992). Group 5 svNTXs had multiple functions in vivo such as myotoxicity, anticoagulant, 
hemorraghic/ hypotensive or bactericidal effects. 
 
In contrast, postsynaptic svNTXs fall into two major groups based on their interaction with 
either nicotinic acetylcholine receptor (nAChR) or L-type calcium channels. The postsynaptic 
neurotoxins that interact with nAChR were subdivided into five subgroups such as short, long, 
weak, kappa, and the unknown group of svNTXs (Groups 6 – 10). Groups 6 – 9 NTXs formed 
a similar folding pattern of three loops adopting the three-stranded antiparallel α-pleated sheet 
but group 10 svNTXs had a non-3 finger fold with one disulfide bond (P24335).  
 
We employed a phylogenetic analysis on the short-chain neurotoxins and found six subgroups. 
Suprisingly, all short-chain neurotoxins originate from the Elapidae family (Figure 3.6). From 
extensive literature search, ten short-chain neurotoxins have been reported to interact with 
muscle-type nAChR (Marchot et al., 1988; Weber and Changeux, 1974; Pillet et al., 1993; 
Gong et al., 1999, 2000). One interesting neurotoxin was fasciatoxin from group 7B-1 
(P14534). It is an unusual short-chain neurotoxin from Bungarus fasciatus (Liu et al., 1989). 
This protein is 63 amino long but has a unique C-terminal tail of PSTPST not found in any 
other short-chain neurotoxins. So far, short-chain neurotoxins are found to interact specifically 
with muscle-type nAChRs. Critical residues that are involved in the molecular recognition of 
toxin-receptor were studied elsewhere by individual chemical modifications (review by Endo 
and Tamiya, 1991). Lys-27 and Lys-47 are critical for receptor binding (Hori and Tamiya, 
1976; Ishikawa et al., 1977; Faure et al., 1983). Pillet et al. (1993) suggested that three 
ionogenic residues Lys-27, Asp-31 and Arg-33 in erabutoxin a from L. semifasciata are 
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Figure 3.6: Classification of snake NTX based on structure, function and phylogenetic information. Only full length 
neurotoxins are included in this classification. Boxed number refers to the total number of neurotoxins sharing the same 
physiological function. Layer 1 denotes the neurotoxin site of action; layers 2 and 3 represent functional and structural 
properties of neurotoxin respectively; layer 4 refers the molecular target of each svNTX layer 5 represents the 




Long-chain neurotoxins from Elapidae family were subclassified into five subgroups. Several 
members of long-chain neurotoxins interact with alpha-7 neuronal nAChR (Group 6B), in 
contrast to short-chain neurotoxins. Phylogenetic analysis could not be performed on this 
group because it has only three members at present. To date, five and three long-chain 
neurotoxins were demonstrated experimentally to interact with muscle-type nAChR (Group 
6A-1 and 6A-2; Figure 3.6) and alpha-7 neuronal nAChR (Group 6B-1) respectively (Ishikawa 
et al., 1977; Chang et al., 1993; Servent et al. 1998). The presence of the fifth disulfide bond 
in long-chain neurotoxins had been implicated in the interaction with neuronal nAChR 
(Servent et al., 2000). Arg-33 was especially important for this binding specificity (Antil et al., 
1999). It would be of great interest if the important residues that interact with these two 
receptors can be delineated. Forty five long neurotoxins were not experimentally determined 
whether they interact with either muscle-type or neuronal nAChR. Phylogenetic analysis 
indicated two main groups within this orphan group: groups 6C-1 and 6C-2 (Figure 3.7E). 
 
svNTXs in group 7A-1 and 7A-2 did not have the consensus Lys-27, Asp-31 and Arg-33 
residues which were implicated in receptor binding (Pillet et al., 1993). However, svNTXs in 
groups 7A-3 and 7A-4 (except P01426) possessed conserved residues of Lys-27, Asp-31 and 
Arg-33 for receptor interaction. Known kappa neurotoxins have 65-66 amino acid residues. 
Their disulphide bonding pattern had not yet been determined. 
 
One distinguishing functional property of kappa svNTXs was their ability to interact with α3 
neuronal nAChR (Figure 3.6, Group 8A). So far, kappa svNTXs were found only in Bungarus 
species and it was believed that they do not interact with muscle nAChR. In addition, the 
specific receptor of six kappa neurotoxins remain unknown (Group 8C-1 and C2) and 
phylogenetic analysis showed two distinct groupings. 
 
Phylogenetic analysis was not performed on weak neurotoxins because of the small number of 
toxins (Groups 9A-C). This group of toxins was found to interact weakly with muscle- and α7-
neuronal nicotinic acetylcholine receptor (Poh et al., 2002; Utkin et al., 2001). To date, our 
database contains 86, 50, 8 and 6 full length short, long, kappa and weak NTXs, respectively. 
Certain postsynaptic neurotoxins (Figure 3.6, group 11) interact with L-type calcium channel 
(Strydom, 1977; Yasuda et al., 1994). Crotoxin (P24027) and phospholipase A2 HTe 
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(Q9PSN5) in group 12 exerted their effect postsynaptically (Bon et al., 1979; Francis et al., 
1995). However, their specific postsynaptic actions are yet to be determined. Three toxins in 
groups 13 and 14 exerted neurotoxic effect both pre- and postsynaptically (Francis et al., 1995; 
Bon et al., 1979). Specific functions of toxins in group 15 are still unknown. They are 
designated as neurotoxin homologs, neurotoxin-like proteins, or neurotoxin isoforms that are 
still not well studied. The individual records of neurotoxin in each group in Figure 3.6 are 
























































Table 3.5: Summary of the individual entries based on GenBank Accession Number of 
each member in each group as depicted in Figure 3.6. Field in red bold and underlined 
indicates the presence of entry in more than one group. Fields in italic (F15, W-III and W-IV) 





































































































































































































































































































































Figure 3.7: Phylogenetic trees performed using parsimony analysis of all the mature svNTX. 
Bootstrap values are the result of 100 replicates. Only bootstrap values of greater than 90 in the each 
internal node are grouped as one group. The outgroup Bee venom PLA2 (Swiss-Prot A59055) and 
Lynx1 (Swiss-Prot AAF16899) were utilised as outgroups for analysis of presynaptic and 
postsynaptic NTXs subgroups respectively. Outgroup was used to give a better representation of the 
evolutionary relationship. A and B: Presynaptic neurotoxins; C: Presynaptic neurotoxins with 
multiple functions; D: long neurotoxins with known receptor binding; E: orphan long neurotoxins; F: 
short neurotoxins with known receptor binding; G: orphan short neurotoxins with unknown receptor 





3.6 Receptor binding studies to test the in silico prediction tool in the database 
 
A native Bc-ntx4 protein (B. candidus toxin with an unknown function) was tested using 
competitive binding studies with 125I-α-Bgt in muscle (Torpedo) nAChR. The binding activity 
studies of Bc-ntx4 on AChR isolated from T.  californica showed weak affinity even in the 
micromolar range (Figure 3.8).  Using the ‘Annotate svNTX’ function in the database, Bc-ntx4 
was predicted to be a weak neurotoxin. This further validates the proof-of-concept of the in 

























Figure 3.8: Competitive binding studies of 125I-α-Bgt and native Bc-ntx4 to nAChR of 


















   
 













Figure 3.9: Output of the annotation tool in svNTXs. Bc-ntx4, a protein of unknown 
function was purified from RP-HPLC and annotate in silico using Annotate svNTX in the 
database. The output result returns a putative function of weak neurotoxin – like activity. This 





















Snake NTXs are a large family of active peptide with considerable sequence homology, but 
with different biological properties. Sequence, functional and structural information on snake 
venom neurotoxins (svNTXs) are scattered across multiple sources such as journals, books, 
and public databases, with very limited functional annotation. A svNTXs database was created 
at http://sdmc.i2r.a-star.edu.sg/Templar/DB/snake_neurotoxin. This database can also be 
found under Swiss-Prot Toxin Annotation Project website (http://www.expasy.org/sprot/). At 
present, 272 NTXs sequences are available in the database and each sequence contains fully 
annotated function and literature references. An annotation tool to aid functional prediction of 
newly identified NTXs as an additional resource for toxinologists. In addition, a classification 
system based on structure-function and phylogenetic relationship derived from the 272 NTXs 

































Scorpion venoms consist of biologically active proteins that contribute to the pathological 
effects of the venom. Traditionally, venoms have been studied with the aim of understanding 
the structure and function of individual toxins and their mechanism of action. The typical 
method is to isolate the protein, followed by biochemical characterization and then 
determination of its biological activity in vitro and in vivo.  
 
Recently, proteomics studies on Buthidae venoms was employed to analyze toxic fractions 
from the venom of Brazilian scorpion, Tityus serrulatus in order to shed light on the molecular 
composition of this venom and to facilitate the search of pharmacologically active compounds 
(Pimenta et al., 2001). Using this method, the researchers are able to detect 380 different 
components present in the scorpion venom. These studies clearly indicate that scorpion venom 
represents a wide variety of proteins. Thus, scorpion venoms may be considered to be a 
naturally occurring ‘library’ of biologically active components that could be potentially 
exploited for drug discovery. To date, Buthus martensi Karsch (BmK) contains more than 70 
different peptides, toxins or homologues (Goudet et al., 2002). These toxins have been found 
to act on Na+, K+ and Cl- channels. 
 
Technological advances in microarray applications now allow for a rapid, broadband analysis 
of the functional effects of substances on expression of genes in cells and tissues. This 
investigation is to assess the use of scorpion venoms as pharmaco-active libraries. The 
hypothesis of the study is that at LD50 concentrations (where no overt phenotypic effect of the 
venom on cells in tissue culture is observed), the venom will produce effects on the gene 
expression profiles of the cells that may lead to some of the scorpion venom components as 





4.2 Purification of scorpion venom using gel filtration chromatography 
 
Gel filtration separates proteins based on their molecular sizes. Protein mixtures are applied to 
a gel filtration column containing a matrix of defined pore size, eluted with an aqueous buffer 
and collected as individual fractions and analysed. Sephadex G50 was used to isolate proteins 
in the range of 1.5 – 30kD. 20mg of lyophilized BmK crude venom was reconstituted in 2 ml 
water and separated using gel filtration. Two fractions were obtained (Figure 4.1). The first 
peak, BmKI consisted of high molecular weight proteins (10-20kD). The second peak, BmKII 

























































4.3 MTT test  
 
The cell survival test (Figure 4.2) showed that BmKII is not toxic to human neuroblastoma 
cells even at a concentration of 500 µg/ml. At 35 µg/ml, the cell survival was at 99%. Hence, 




















Figure 4.2: Cell survival test of human neuroblastoma cells treated with various 
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4.4 Total RNA isolation 
 
Total RNA was isolated from human neuroblastoma cells treated with BmKII at a 
concentration of 35 µg/ml and incubated for 18hrs. The intregrity of RNA was found to be 
acceptable for further studies as they showed two distinct bands for 28S and 18S ribosomal 










Figure 4.3: Total RNA isolation from human neuroblastoma cells treated with 35µg/ml 




4.5 Microarray analysis 
 
Neuroblastoma cells were treated with partially purified BmKII (35 µg/ml) for 18 hrs. The 
global gene expression changes were monitored by microarray genechip procedure. Results 
from microarray analysis showed 875 genes that were four-fold upregulated upon treatment 
with BmKII fraction. The 875 genes were analyzed in terms of their function using molecular 
information available at http://www.affymetrix.com and published journals in NCBI database. 
The summary of the function of 875 genes is listed in Table 4.1. From the microaray analysis, 
ten genes were finally selected. They were found to be involved in neurogenesis and 
angiogenesis pathways as well as other genes involved in metabolic pathway, 
neurotransmission, development and signaling pathway. These ten genes were listed in Table 









































Table 4.1: Summary of the 875 genes function that was altered by treatment of BmKII in 
human neuroblastoma cell. Functions of the genes were annotated using published literature 







Change in of gene expression




















Inhibitor of growth suppressor unchanged
Metabolic pathway +
Neurogenesis +
Protein  biosynthesis +
Protein degradation/turnover +
RNA binding protein -
RNA synthesis/processing unchanged
Signalling pathway +



















Table 4.2:  List of the ten selected genes after microarray gene chip analysis. The gene 

















Gene name Fold change
Neurogenesis
Amphiregulin 13.9





GABA (A) receptor alpha 5 103
Annexin A2 4.3
Galanin 9.2
Cysteine rich protein 1 803
Aldehyde dehydrogenase 1 81.6
Neuregulin 1 7.8



























Figure 4.4: Cluster 1 genes identified using Genesis® software.  Two genes, GABA (A) 
receptor and neuregulin 1 in this cluster were selected for further studied.  Lane 1: untreated 
neuroblastoma cell; lane 2: neuroblastoma cell treated with 35 µg/ml BmK II for 18 hrs. Green 
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caspase 8, apoptosis-related cysteine protese (CASP 8)
myosin, heavy polypeptide 13, skeletal muscle (MYH13)
hypothetical protein FLJ13166
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regulated in glioma (RIG)
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Figure 4.5: Cluster 2 genes identified using Genesis® software.  Fibroblast growth factor, 
FGF2 in this cluster which is involved in neurogenesis was further investigated. Please refer to 


























fibroblast growth factor 2 (FGF2)
FEA=EST/DB_XREF=gi:10809262
FK506 binding protein 1B (FKBP1B)
vaccinia related kinase 2 (VRK2)
cDNA FLJ11303
hypothetcial protein (RIF)
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Figure 4.6: Cluster 3 genes identified using Genesis® software. Krit-1 is a gene involved in 
















tryptophan  2,3-dioxygenase 
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tetratricopeptide repeat domain 3
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Figure 4.7: Cluster 4 genes identified using Genesis® software. Calponin 3 is a gene 
involved in angiogenesis and its gene expression was further studied. Please refer to Figure 4.4 
for legends. 
FEA=EST/DB_XREF=gi:6704806
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Figure 4.8: Cluster 5 genes identified using Genesis® software. Aldehdye dehydrogenase 
was upregulated 81.6 fold and its gene expression profile was further investigated. Please refer 
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insulin receptor substrate-2 (IRS2)
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fibronectin leucine rich transmembrane protein 3 (FLRT3)
FEA=EST/DB_XREF=gi:5177504






gene encoding homeobox related protein
FEA=EST/DB_XREF=gi:AL578310
hypothetical protein DKFZp586H0623
cell death regulator aven
cDNA DKFZp5860051
estrogen-responsive B box protein
cDNA: FLJ23564
fatty acid coenzyme A ligase
hypothetical proteinFLJ12525









mitochondrial ribosomal protein S12
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Figure 4.9: Cluster 6 genes identified using Genesis® software. Cysteine-rich protein 1 




fibroblast growth factor receptor 2
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hypothetical protein FLJ20495  




Figure 4.10: Cluster 7 genes identified using Genesis® software. Three genes in this cluster, 






aldo-keto reductase family 1 (AKR1B1)
Clone MGC: 5333
UDP-glucose dehydrogenase (UGHD)
aldo-keto reductase family 1 isoform
dihydrodiol dehydrogenase




insulin-like growth factor-binding protein 4
pseudochlordecone reductase
tumor necrosis factor superfamily
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Sjorgens syndromesoleroderma autoantigen 1 (SSSCA1)
Ribonucleotide reductase M2 polypetide
IAP homolog C (MIHC)
Periplakin (PPL)
Annexin A2 (ANXA2)
ATP binding cassette, sub-family C
Thioredoxin reductase 1, slone MGC:1920
Hypothetical protein FLJ10430
Brain acid-soluble protein 1
CCAAT enhancer binding protein (CEBP)
MHC class I polypeptide-related sequence B (MICB)
LPS-induced TNF-alpha factor (PIG7)
Potassium intermediate small conductance calcium-activated channel




Nuclear receptor subfamily O (NROB1)
Gravin
Galanin
Aldehyde dehyrogenase 3 (ALDH3)
Heat-shock 70kD protein 1A
Id-1h
diaphorase
inhibitor of DNA binding 3
FEA=EST/BD_XREF=gi:11769659
Leucine zipper, down-regulated in cancer 1
Midline 1
Solute carrier family 21











Small inducible cytokine subfamily A
FEA=EST/DB_XREF=gi:13545549
J domain containing protein 1 (JDP1)






Neuregulin 1 (NRDG), transcript variant 1 SMDF
Annexin A4
Proliferating cell nuclear antigen
Pirin
Tissue inhibitor of metalloproteinase 3 (TIMP3)





Insulin-like growth binding protein 6
KIAA0307 gene product





Hematological and neurological expressed 1
mRNA for hepatocyte nuclear factor-3
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Fatty acid co-enzyme A ligase
40S ribosomal protein S27 isoform
dickkopf homolog 1 (DKK1)





4.6 Quantitative Real-time PCR analysis of genes affecting neurogenesis and angiogenesis 
 
Quantitative real-time PCR is one of the most powerful and sensitive gene analysis techniques. 
Its versatility has made it one of the fastest growing tools in molecular biology. The easier way 
to monitor fluorescence in quantitative PCR is to use a dye that emits light upon intercalation 
in double stranded DNA (Wittwer et al., 1997). The intensity of the fluorescent signal is 















Figure 4.11: Schematic representation of real-time PCR with the SYBR Green I dye. 
SYBR Green I dye (black diamonds) becomes fluorescent (green diamonds) upon binding to 
double-stranded DNA, providing a direct method for quantitating PCR products in real time. 
Gray arrow head represent the forward primer. 
 
SYBR® Green assay was chosen in this studies as it is cheaper and relatively easy to use than 
TaqMan® probes. Ribosomal RNA present in the total RNA sample is used as an internal 
standard. Optimum concentration of total RNA for real-time PCR detection was found to be 
100ng. A non-template control in which sterile buffer replaced template RNA served as the 
negative control. The amount of target was normalized to ribosomal RNA. The following 






∆CTS = ∆CT (sample) – ∆CT 18S RNA 
∆∆CTS = ∆CTS – ∆CTS (of respective control) 
Relative gene expression = 2-∆∆CTS 
 
In order to confirm the level of gene expression in the microarray study, real-time PCR was 
performed on these ten genes using SYBR® Green assay.  Approximately 100 ng of total RNA 
was used for real-time PCR experiment. Krit1 and calponin gene expression were found to be 
downregulated in both microarray and real-time PCR (Table 4.3). The other eight genes were 
found to be upregulated in both microarray and real-time PCR.  In summary, the gene 
expression changes in microarray experiment were positively confirmed using real-time PCR 















Table 4.3: Changes in gene expression level as detected by microarray and real-time 









Microarray Real-time Real-time SD 
Amphiregulin 14.00 2.90 0.40
Krit1 -5.00 -22.00 0.38
FGF2 5.00 1.10 0.23
Calponin 3 -6.80 -60.00 1.43
GABA(A) receptor 104.00 3.10 0.25
Annexin A2 4.30 5.20 0.02
Galanin 9.20 3.20 0.13
Cysteine rich protein 803.00 2.50 0.26
ALDH 81.00 433.00 0.13





























Figure 4.12: Gene expression profiles of ten genes studied using microarray and real-
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4.7 Further purification of BmKII using reverse phase-high performance liquid 
chromatography 
 
After confirming the expression of the ten genes, BmKII was then subjected to RP-HPLC. The 
RP-HPLC separation of any peptide or protein mixture is dependent upon the strength of the 
hydrophobic interaction of each component in the mixture with the hydrophobic surface of the 
column matrix and the elution strength of the organic solvent in the mobile phase. As the 
concentration of the organic solvent increases, the elution of the polar species occurs first 
followed by the elution of non-polar species. Peptide or protein mixtures are applied to a RP 
column containing a chromatographic matrix with a defined hydrophobic character. The 
absorbed peptides or proteins are eluted in order of least to most strongly bound molecules by 
increasing the organic solvent concentration in the elution buffer, collected as individual 
chromatographic fractions, and analysed separately. The main difference between hydrophobic 
interaction and reverse phase matrices is the relative hydrophobicity of the matrix, with the 
reverse phase matrix having greater hydrophobicity.  
 
In this method, the stationary phase is hydrophobic (non-polar), while the mobile phase is 
polar. The functional groups normally attached to the silica gel are the alkyl chains such as 
C18 (octyl). Venom polypeptides and toxins have compact spatial structure which allows their 
charge and hydrophobic character to be expressed mainly on the surface of the molecule. 
 
Partially purified BmKII venom was successfully separated into discernable peaks by RP-
HPLC using the Jupiter C18 column. The column was equilibrated with 0.1% trifluoroacetic 
acid (TFA). The absorbed protein was eluted with 0.1% TFA at a flow rate of 1 ml/min. A 
linear gradient (30 – 50%) of 0.1% TFA in water (Buffer A) and 0.1% TFA in 80% 
acetonitrile (Buffer B) was applied for 20 min. Several proteins peaks were obtained during 
the gradient elution. Once the protein fractions are collected, they are dried by speed-vac, 
resuspended in sterile water and re-dried by speed vac again. In this way, the BmKII fraction 
was divided into nine small subfractions (Figure 4.13). Each subfraction was pooled and its 
protein concentration determined using Bradford assay. The individual fraction was examined 
by real-time PCR (Table 4.4 and Figure 4.14) for its effects on expressions of genes in 



































































Figure 4.13: RP-HPLC of BmKII from scorpion venom. This profile shows the BmKII 
fractions containing small molecular weight protein of <7 kD. This BmKII fraction was 
divided into nine subfractions as indicated by the red bar. Each subfractions were tested on 









4.7.1 Effects of BmKII fractions RP1 – 9 on gene expression of ten selected genes 
 
Figure 4.14 shows the gene expression profile obtained using nine subfractions from BmKII. 
Krit, galanin, FGF2 and amphiregulin genes were consistently upregulated in fraction 7. 
Fraction 5 of BmKII was able to cause an increase of 5.7 fold and 28 fold gene expression in 
neuregulin and GABA (A) receptor gene respectively. In addition, fraction 6 caused 10.8 fold 
upregulation of amphiregulin gene. Hence, RP5, 6 and 7 could potentially contain 
modulator(s) for these six genes.  
 
These three selected fractions were found to contain more than one species of proteins and 






























































































Table 4.4: Relative level of gene expression of the six genes using nine subfractions from 
BmKII. 
 
4.7.2 Further separation of fractions RP5-7 using RP-HPLC 
Fractions RP5-7 were selected for further purification as they might potentially contain interesting 


















Figure 4.15: RP-HPLC of fraction RP5.  RP5 of BmKII was collected and injected into Jupiter C18 
µBore RP-HPLC column. Buffers used were Buffer A: 0.1% (v/v) TFA in water, Buffer B: 0.1% (v/v) 
TFA in 80% acetonitrile. Elution was performed at a linear gradient of 5 – 100 % in 20 min. Flow rate 
was 1 ml/min. RP5 fraction was pooled and divided into three different subfractions of RP5.1 – RP5.3 
as indicated by the red bar. Each subfractions were tested on neuroblastoma cells and the gene 
expression profile was studied using real-time PCR (Figure 4.18). 
Krit1 Galanin FGF2 Amphiregulin Neuregulin GABA(A)
Fold SD Fold SD Fold SD Fold SD Fold SD Fold SD
RP1 2.23 0.09 1.65 0.16 0.58 0.13 3.33 0.48 1.80 0.47     5.31 0.48
RR2 3.86 0.77 3.80 0.77 2.30 0.77 5.00 0.90 4.30 0.80     14.60 0.78
RP3 3.00 0.40 1.76 0.35 1.60 0.38 8.60 0.36 4.74 0.41     8.40 0.37
RP4 2.80 0.40 2.12 0.40 0.98 0.40 4.80 0.45 0.79 0.44     4.20 0.40
RP5 4.00 0.42 5.66 0.10 2.95 0.13 10.60 0.39 5.70 0.23     28.00 0.24
RP6 3.70 0.06 4.87 0.06 2.90 0.14 10.80 0.07 1.13 0.15     2.80 0.10
RP7 7.40 0.25 7.64 0.27 6.00 0.27 11.00 0.17 4.60 0.17     5.00 0.29
RP8 1.66 0.10 2.00 0.21 2.10 0.18 1.60 0.18 0.47 1.08     3.00 0.10



























Figure 4.16: RP-HPLC of fraction RP6. RP6 of BmKII was collected and injected into 
Jupiter C18 µBore RP-HPLC columns. Buffers used were Buffer A: 0.1% (v/v) TFA in water, 
Buffer B: 0.1% (v/v) TFA in 80% acetonitrile. Elution was performed at a linear gradient of 5 
– 100 % in 20 min. Flow rate was 1 ml/min. RP6 fraction was divided into four different 
subfractions of RP6.1 – RP6.4 as indicated by the red bar. Each subfraction was tested on 


































































Figure 4.17 RP-HPLC of fraction RP7. RP7 of BmKII was collected and injected into 
Jupiter C18 µBore RP-HPLC column. Buffers used were Buffer A: 0.1% (v/v) TFA in water, 
Buffer B: 0.1% (v/v) TFA in 80% acetonitrile. Elution was performed at a linear gradient of 5 
– 100 % in 20 min. Flow rate was 1 ml/min. RP7 fraction was pooled and divided into three 
different subfractions of RP7.1 – RP7.4 as indicated by the red bar. Each subfraction was 
tested on neuroblastoma cells and the gene expression profile was studied using real-time PCR 






























































4.7.3 Effects of BmKII fraction RP5, 6, and 7 on six selected genes 
 
The individual fractions (from RP5–7) were subjected to RP-HPLC and tested on 
neuroblastoma cells. The changes in gene expression of the six genes were monitored by real-
time PCR. The highest gene upregulation was consistently found in RP5.2 (Figure 4.18). 
Interestingly, RP6.3 caused 10 fold downregulation in GABA (A) receptor gene (Table 4.5). 
This fraction might contain a modulator that can regulate GABA (A) gene level in 
neuroblastoma cells. RP7.1 and RP7.2 show significant upregulation of the six genes. As the 
pattern of gene upregulation was similar to that of subfractions RP5 and RP6, further analysis 








































Table 4.5: Relative level of gene expression of the six genes using subfractions of fractions 
RP5, 6 and 7. 
 
4.7.4 Purification of the five fractions using RP-HPLC and determination of protein mass 
using MALDI-TOF.  
 
Fraction RP5.2, 6.2, 6.3 and 6.4 were selected for further purification in RP-HPLC and this 
was shown in Figures 4.19-4.22. MALDI-TOF is a sensitive tool for molecular weight 
determination of proteins. Fractions 5.2G1, 6.2F4, 6.3F4, 6.3F5 and 6.4F7 were subjected to 






















Krit1 Galanin FGF2 Amphiregulin Neuregulin GABA(A)
Fold SD Fold SD Fold SD Fold SD Fold SD Fold SD
RP5.1 3.50 0.33 2.84 0.33 1.92 0.34 3.75 0.33 3.12 0.33 1.91 0.35
RP5.2 7.27 0.33 6.50 0.33 3.00 0.33 10.46 0.33 7.24 0.33 2.60 0.35
RP5.3 1.75 0.28 1.45 0.28 1.50 0.28 2.02 0.28 1.51 0.28 1.30 0.28
RP6.1 3.22 0.23 3.20 0.24 1.70 0.23 4.46 0.23 3.73 0.23 1.83 0.24
RP6.2 6.68 0.23 5.60 0.23 2.60 0.24 7.27 0.23 5.70 0.23 2.05 0.24
RP6.3 3.47 0.23 3.00 0.23 1.80 0.26 3.63 0.23 3.24 0.23 0.10 0.31
RP6.4 2.16 0.28 2.04 0.29 1.52 0.29 3.28 0.28 2.32 0.28 2.30 0.29
RP7.1 1.55 0.06 4.80 0.07 1.36 0.12 6.74 0.07 5.47 0.06 3.90 0.06
RP7.2 1.68 0.06 4.40 0.11 1.53 0.07 5.68 0.06 4.36 0.06 1.43 0.06
RP7.3 1.41 0.05 2.10 0.05 1.14 0.04 2.56 0.06 2.03 0.04 1.04 0.06






























Figure 4.19: Fraction RP5.2 separated in Jupiter C4 µBore RP-HPLC column. Buffers 
used were Buffer A: 0.1% (v/v) TFA in water, Buffer B: 0.1% (v/v) TFA in 80% acetonitrile. 
Elution was performed at a linear gradient of 5 – 100 % in 20 min. Flow rate was 1 ml/min. 
Fraction RP5.2G1 was obtained and treated in neuroblastoma cells. Each subfraction was 


















































































Figure 4.20: Fraction RP6.2 separated in Jupiter C4 µBore RP-HPLC column. Buffers 
used were Buffer A: 0.1% (v/v) TFA in water, Buffer B: 0.1% (v/v) TFA in 80% acetonitrile. 
Elution was performed at a linear gradient of 5 – 100 % in 20 min. Flow rate was 1 ml/min. 
Fraction RP6.2F4 was obtained and treated in neuroblastoma cells. Each subfraction was 































































Figure 4.21: Fraction RP6.3 separated in Jupiter C4 µBore RP-HPLC column. Buffers 
used were Buffer A: 0.1% (v/v) TFA in water, Buffer B: 0.1% (v/v) TFA in 80% acetonitrile. 
Elution was performed at a linear gradient of 5 – 100 % in 20 min. Flow rate was 1 ml/min. 
Two peaks of fraction RP6.3F4 and RP6.3F5 were obtained and treated in neuroblastoma 
cells. Each subfraction was tested on neuroblastoma cells and the gene expression profile was 









































































Figure 4.22: Fraction RP6.4 separated in Jupiter C4 µBore RP-HPLC column. Buffers 
used were Buffer A: 0.1% (v/v) TFA in water, Buffer B: 0.1% (v/v) TFA in 80% acetonitrile. 
Elution was performed at a linear gradient of 5 – 100 % in 20 min. Flow rate was 1 ml/min. 
Fraction RP6.4F7 was obtained and treated in neuroblastoma cells. Each subfraction was 
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Figure 4.23: MALDI-TOF of the five fractions. A: RP5.2G1; B: RP6.2F4; C: RP6.3F4; D: 




















































4.7.5 Effects of BmKII subfractions RP5 and 6 on six selected genes 
 
Fractions RP5.2, RP6.2, RP6.3 and RP6.4 were subjected to another round of RP-HPLC and 
found to contain single peaks (Figures 4.19- 4.22). Hence, they were considered a relatively 
pure sample for further characterization. The MALDI-TOF analysis confirms that all fractions 
contain a major peak of about 7kD (Figures 4.23). Two concentrations of 10 ng/ml and 50 
ng/ml of fractions RP5.2G1, RP6.2F4, RP6.3F4, RP6.3F5 and RP6.4F7 were tested on 
neuroblastoma cells and the gene expression changes measured using real-time PCR. Figure 
4.24 and Table 4.6 show the gene expression profile of Krit1, galanin, FGF2, amphiregulin, 































Table 4.6: Relative level of gene expression of the six genes using 10 ng/ml subfractions of 




























Krit1 Galanin FGF2 Amphiregulin Neuregulin GABA(A)
Fold SD Fold SD Fold SD Fold SD Fold SD Fold SD
RP5.2G1 1.08 0.04 0.40 0.02 0.10 0.10 4.40 0.09 0.08 0.08 0.45 0.01
RP6.2F4 1.70 0.17 1.63 0.38 0.14 0.14 5.38 0.22 0.15 0.15 0.73 0.14
RP6.3F4 1.87 0.18 0.21 0.27 0.27 0.27 3.50 0.17 0.19 0.19 0.53 0.20
RP6.3F5 1.69 0.42 0.77 0.53 0.42 0.42 6.13 0.42 0.42 0.42 0.67 0.43
































Table 4.7: Relative level of gene expression of six genes using 50 ng/ml subfractions of 
fractions RP5 and 6. 
 
At low concentration of 10 ng/ml treatment, amphiregulin and krit1 genes are consistently 
upregulated. Galanin, FGF2, neuregulin and GABA (A) genes showed similar pattern of gene 
downregulation. However a higher concentration of 50 ng/ml treatment showed very varied 
level of gene expressions. Galanin was the most highly upregulated gene in RP5.2G1 (Table 



























Krit1 Galanin FGF2 Amphiregulin Neuregulin GABA(A)
Fold SD Fold SD Fold SD Fold SD Fold SD Fold SD
RP5.2G1 1.19 0.29 17.55 0.10 2.60 0.11 2.10 0.12 2.44 0.10 5.80 0.11
RP6.2F4 2.20 0.14 1.44 0.17 0.77 1.21 1.10 0.11 0.10 0.12 3.90 0.17
RP6.3F4 8.00 0.23 4.10 0.11 4.30 0.14 4.20 0.15 3.38 0.10 11.20 0.19
RP6.3F5 1.00 0.21 0.80 0.10 0.90 0.05 0.76 0.08 0.85 0.05 3.72 0.13
RP6.4F7 1.70 0.44 1.80 0.42 2.10 0.41 1.70 0.42 1.50 0.42 5.21 0.43
Results 
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upregulated across the five treatments. In RP6.3F5, all the genes except for GABA (A) 
receptor were downregulated (Table 4.7 and Figure 4.25). 
 
4.8 N-terminal sequencing of the selected five subfractions RP5 and 6 
 
N-terminal sequencing was performed on fractions RP5.2G1, RP6.2F4, RP6.3F4, RP6.3F5 and 
RP6.4F7 purified on RP-HPLC column was determined by automatic Edman degradation 
using a Procise-HT (Model 494) pulsed liquid-phase Protein Sequencer attached to a 140C 
PTH amino acid analyzer (Applied Biosystems, Inc., USA).  The sample containing 1-5 nmol 
of protein was dissolved in 200 µl of 0.1% TFA and 10 µl was used for sequence 
determination. 
 
The N-terminal sequence of the 5 fractions was determined up to 27 amino acid residues. The 























Table 4.8: Results of the N-terminal sequencing of five fractions. Amino acid residues are 
indicated by the standard one-letter abbreviations.  
 
Protein fraction
Residue RP5.2G1 RP6.2F4 RP6.3F4 RP6.3F5 RP6.4F7
number 7202 Da 7016 Da 7031 Da 7024 Da 7028 Da
1 V D G G G
2 R R R R R
3 D D D D Y
4 G A A A I
5 F Y Y Y A
6 I I I I D
7 A A A A S
8 D D D D E
9 P P S S
10 K E E E
11 N N N
12 A - -
13 V T T
14 Y Y Y
15 - T T
16 - - -
17 A A A
18 G L K
19 N N N







27 T T  
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Blast search on the five fractions showed highest percentage similarity to known neurotoxins 
from Chinese scorpions (Table 4.9). Protein RP5.2G1 showed similarity to bukatoxin and 
toxin BmKT precursor, both which are alpha toxins from B. martensi. Both toxins bind to the 
receptor at site 3 of the sodium channel and specifically prolong the action potential by 
blocking the sodium channel inactivation. The interaction of alpha-toxin to the receptor is 
voltage dependent.  RP6.2F4 has similar identity to two toxins, BmK-IV and BmKalphaTx13 
both alpha-type neurotoxins. These toxins bind to sodium channels and inhibit the inactivation 
of the activated channels, thereby blocking neuronal transmission. It is interesting that 
fractions RP6.3F4 and 6.3F5 displayed high protein sequence similarity with makatoxin I. 
Both toxins shared similar sequence except at position 21 where leucine is replaced with lysine 
in RP6.3F5. Makatoxin I is also an alpha toxin, where it binds to sodium channel and prolong 
the action potential by blocking the sodium channel inactivation. In addition, fraction RP6.4F7 
displayed highest protein similarity to makatoxin I and BmKVIII.  Both toxins belong to the 



















Scorpion venom BmKII was found to alter the gene expression pattern in human 
neuroblastoma cell. 875 genes were upregulated by four-fold in our preliminary microarray 
study. Six genes involved in neurogenesis and angiogenesis pathways were selected for further 
gene expression analysis using real-time PCR. Crude venom BmKII was further separated into 
Fraction Toxin identity Percentage GenBank 
similarity Accession Number
RP5.2G1 Bukatoxin 87% P82815
Toxin BmKT precursor (BmK T) (Antitumor-analgesic peptide) 87% Q95P69
RP6.2F4 Alpha-like neurotoxin BmK-IV (BmK4) (BmK-M4) 78% P58328  
Alpha-neurotoxin TX13 precursor (BmKalphaTx13) 78% Q9NJC8
RP6.3F4 Makatoxin I (MkTx I) 88% P56569 
RP6.3F5 Makatoxin I (MkTx I) 84% P56569 
RP6.4F7 Makatoxin I (MkTx I) 80% P56569




nine individual fractions and fractions 5, 6 and 7 were found to modulate gene expression of 
six of the genes. Fraction RP5.2 consistently caused highest gene upregulation in the six 
chosen genes with RP6.3 causing downregulation in GABA (A) receptor. The major toxin in 
the five subfractions was found to be alpha-toxins from Buthus martensi. Alpha-toxins have 
been shown to bind to sodium channel to cause prolonged channel inactivation. This study has 







































































5.1 Neurotoxin database 
 
A specialized database has been constructed using bioinformatics and for structure-function 
studies on snake venom neurotoxins. The toxins data that are scattered across all databases are 
finally consolidated into a single repository. This cleaned and annotated data set can give a 
better insight into data representation, and also into the structure-function relationships of the 
svNTXs.  
 
Currently, the svNTXs database contains 272 entries of neurotoxins. This number is expected 
to increase exponentially with time. BioWare provides a platform for easy update of new data 
from any public databases.  
 
The objectives of building a svNTX database for improved data management and 
comprehensive analysis of the data have been fulfilled in this study. The svNTX database is 
largely complied from public databases which can be prone to errors. Any errors or mistakes in 
the database have been reduced by cross checking with published journal. This database is 
intended to aid in the molecular analysis snake venom neurotoxins by facilitating the selection 
of important experiments and design of experimental protocols. Collected dataset of svNTXs 
have allowed for better structure and functional classification. This information on the 
structural and functional prediction had lead to a building of a prediction tool in the database. 
 
We tested native Bc-ntx4 protein, a B. candidus toxin with unknown function, using competitive 
binding studies with 125I-α-Bgt in both muscle (Torpedo) nAChR . The binding activity studies 
of Bc-ntx4 on AChR isolated from T.  californica showed weak binding (Figure 3.8). Using 
the ‘Annotate svNTX’ function in the database, Bc-ntx4 was predicted to be weak neurotoxins. 




The second aim of this bioinformatics study was to classify svNTXs according to structure and 
function relationship based on several approaches. The first approach was to study cysteine 
pairing pattern in the svNTXs dataset. It revealed 12 interesting disulphide pairing pattern.  
Information for disulfide bridge patterns were only found in 251 entries but were absent in 21 
entries. Some of the cysteine pairing groups had one or two members which formed 
insufficient representatives for classification, as these patterns could be due to sequencing 
errors. In addition, fasciculins (that act presynaptically by inhibiting acetylcholinesterase) and 
short svNTXs (that act postsynaptically and bind to nAChR) share similar disulfide pairing pattern 
but exhibited very different functions (Table 3.3). Hence, disulfide pairing pattern cannot be used 
as an indicator for structure-function prediction. 
 
The phylogenetic relationships of the three finger snake venom toxins have been extensively 
reviewed (Dufton 1984; Tamiya and Yagi, 1985; Dufton and Hider 1991; Fry et al., 2003). 
Dufton (1984) had systematically examined 139 homologous short and long svNTXs and 
cytotoxins from elapid snake venoms and grouped the toxins according to similarity. In spite 
of this, no clear picture has emerged to connect the structure-function relationship based on 
phylogeny. Phylogenetic studies provide for better understanding of any evolutionary pattern in 
svNTXs. Protein parsimony analysis available in PHYLIP statistical software was used to classify 
the svNTXs. 15 specific evolutionary groups were obtained and all the members shared similar 
function. With the exception of several members, some entries in each group have multiple 
functions. It could be due to the fact that additional functions in other members are yet to be found. 
Interestingly, some neurotoxins exhibit multiple functions unlike toxins from scorpion venoms. 
Some of the toxins that exhibit multiple functions are listed in Table 3.6. 
 
The svNTXs database revealed several interesting features. A thorough systematic 
characterization of svNTXs, to our knowledge has not been carried out. We fill this gap with 
the construction of clear and concise classification table based on structure-function and 
phylogeny relationship (Figure 3.6). This table can also be used to predict function of newly 
discovered snake neurotoxin.  
The svNTXs database had several special features which are sets it apart from other sequence 
databases: (i) 3-D structure feature viewer (ii) functional annotation of individual entries, and 




The field of toxinology is growing rapidly especially in terms of information provided by 
cDNA and protein data in the public database. The availability of a specialized database allows 
easier systematic data analysis and also enables incremental data analysis upon updating with 
new data. This database and analysis system will serve as an example for bioinformatics 
application in the studies of snake neurotoxins. 
 
The present work has laid the foundation for a more detailed and more systematic studies of 
svNTXs.  The prediction module available in our database can be used for functional 
prediction of any novel neurotoxins cloned or characterized in the future. We envisage that 
increasing number of svNTXs in the future will make bioinformatics an attractive tool to speed 
up experimental research. 
 
5.2 Conclusion and future studies 
 
This section focused on a systematic bioinformatics approach towards building a database for 
svNTX and their structure-function study. The database contains functional and structural 
information on svNTX gathered from various sources. Each record in the database, originally 
from the public databases, was enriched by extracting information from the literature and 
incorporating this into the svNTX database. The publically-available database may facilitate 
bioinformatics study of structure-function of svNTX. 
 
In addition to the tools available in svNTX, BLAST search, Query svNTX, Structure viewer, 
Download FASTA and Annotate svNTX, this database can be further enriched with tools that 
allow dynamic phylogeny. Dynamic phylogeny will allow users to construct phylogeny trees 
on the spot in the database Then, any new evolutionary relationship of novel sequences can be 
checked with the existing sequences for structure-function prediction. As a proof of concept, 
an experimental procedure was carried for an unknown snake neurotoxin. This toxin was 







5.3 Screening of scorpion venom for therapeutic peptides 
 
Scorpion venoms are a rich resource of bioactive peptides. Accumulated data have 
demonstrated that scorpion neurotoxins affect the ion permeability of excitable cells by 
specific interaction with calcium, potassium, sodium, and chloride ion channels (Catterall, 
1980). Detailed knowledge about the biological properties of the venom of the Chinese 
scorpion, Buthus martensi Karsch (BmK), has been limited to neurotoxic components present 
in the venom of this species. BmK has been used in traditional Chinese medicine to treat 
epilepsy, antihyperalgesic and reversal effects on circulation failure (Zhou et al., 1989; Wang 
et al., 2000; Peng et al., 2002). Although many peptides have been identified in this venom, no 
modulators of genes affecting biological processes such as angiogenesis and neurogenesis 
have been identified.  
 
The effect of BmKII fractions on cell viability was first tested using MTT assay. As shown in 
Figure 4.2, the venom is non-toxic to cells. This is further supported by the evidence that the 
scorpion venom showed a LD50 value of 2.4 mg/kg following intraperitonial injection and a 
minimum lethal dose (MLD) of 0.074 mg/kg after intracerebroventricular injection in mice 
(Goudet et al., 2002).  From the MTT assay, cells were found to show a 95% cell viability at 
35 µg/ml of BmKII.  
 
Thus gene expression studies were carried out at 35 µg/ml BmKII using a human 
neuroblastoma cell line. Ten interesting genes that are involved in angiogenesis, neurogenesis 
and ion channel modulation have been identified. In order to confirm the microarray results, 
real-time PCR was used and the results supported each other.  
 
One hypothesis was that BmKII partially purified fractions might possibly contain modulators 
of these ten genes. The BmKII fraction was further purified into nine different subfractions, 
termed RP1 – 9 using RP-HPLC. Each fraction was tested individually and the expression of 
genes were monitored using using real-time PCR. Fractions RP5, 6, and 7 caused the greatest 
Discussion 
 134
change in gene expression of those ten putative genes. Hence, these fractions were used for 
further studies.  
 
From extensive literature search six genes: galanin, krit1, neuregulin, GABA(A) receptor α5 
subunit, amphiregulin and FGF2, are involved in many biological function in vivo such as 
nerve regeneration, angiogenesis,  cell proliferation and survival. The summary of the six 
genes functions are described as below.  
 
5.3.1 Galanin  
 
Neuropeptides are a heterogenous class of biologically active substances that modulate the 
function of neuronal circuits. These neuropeptides co-localized with the classical 
neurotransmitters and determine a unique immunochemical profile of distinct neuronal 
populations throughout the brain (Mazarati et al., 2001). These neuropeptides are released 
from neurons in response to stimulus entering the spinal cord, binds to specific receptors on 
target neurons and modulate the action of classical neurotransmitter in either negative or 
positive fashion (Drake et al., 1994; Boehm and Betz 1997).  
 
Galanin is a 29 or 30 amino acids long neuroendocrine peptide, originally isolated by 
Tatemoto et al. 1983 from porcine upper intestine. Galanin has been identified in many 
species, including rodents and primates (Langel and Bartfai, 1998). It is not a member of any 
known family of neuropeptides, despite repeated efforts to discover related peptides. This 
protein binds to family of receptors that belong to a superfamily of G-protein coupled 
receptors (Amiranoff et al., 1989; Consolo et al., 1991). To date, three different receptor 
subtypes of galanin receptor (GALR) have been cloned (GalR1, GalR2 and GalR3) from 
rodents and humans (Mazarati et al., 2001; Figure 5.1). Ligand and receptor interactions 
modulates release of neurotransmitters, affects learning and memory feeding, nociception and 
nerve regeneration (Vrontakis et al., 2002). 
 
Galanin mRNA and protein are found in specific neuronal systems in the brain, spinal cord, as 
well as peripheral nervous system (Zhang et al., 1993a & b, 1995; Merchenthaler et al, 1993). 
The protein exerts a strong neuroendocrine effect by modulating the release gonadotrophins, 
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insulin, prolactin, growth hormone, and somastostatin (Vrontakis et al., 1991; Bartfai et al., 
1993). It is a potent inhibitor of the release of a number of neurotransmitters and hormones, 
including acetylcholine, dopamine, insulin and gastrin (Rossowski and Coy, 1989; Pramanik 
and Ogren, 1992). 
 
A distinctive feature of galanin gene expression is its dramatic upregulation by estrogens, after 
nerve injury, in the basal forebrain of Alzheimer’s patients and during development (Vrontakis 
et al., 1989; Villar et al., 1989; Crawley, 1993; Xu et al., 1996). The galanin mRNA and 
protein levels also change in some acute and chronic inflammation especially the neurons 
where galanin is strongly upregulated following inflammation (Ji et al., 1995). 
 
In the preliminary screening of all the BmKII fractions, galanin gene was upregulated the most 
in RP5.2G1. This may be proved useful as a potential agonist. Galanin agonists have been 
used in preventing anoxic damage and have additional advantage over Ca2+ channel blockers. 
An application of galanin receptor agonists would be useful in preventing oxidative damage 
during open heart surgery.  
 
Galanin receptor agonist can also be used to enhance the release of growth hormone without 
effecting the diurnal rhythm of this process and therefore appear as attractive agents to 
increase growth hormone secretion in humans (Bauer et al., 1986). Galanin receptors seem to 
control prolactin release from pituitary adenomas and are considered as targets for endocrine 
manipulation of these tumors.  
 
In addition, galanin agonist although not a potent analgesic agent on its own, appears to 
prolong the morphine analgesia four-to eightfold. This may contribute to the reduction of 





















Figure 5.1: Galanin receptors and their transduction mechanisms. The first galanin 
receptor was cloned from human Bowes melanoma cells by Habert-Ortoli et al., (1994). 
Thereafter, two more galanin receptors, GAL2 and 3 have been cloned and the signal 
transduction pathways have been determined for all the three receptors. GAL1 and GAL3 
receptors can induce hyperpolarization and inhibit adenylyl cyclase (AC). AC can be inhibited 
via GAL2 receptors. In addition, GAL2 receptors can also stimulate phospholipase C (PLC), 
resulting in mobilization of Ca2+ and activation of protein kinase C (PKC) via diacylglycerol 
(DAG). There is also evidence for the activation of the mitogen-activated protein kinase 




Cell growth and differentiation are regulated in part by the specific interaction of secreted 
growth factors and their membrane-bound receptors. Receptor-ligand interaction results in 
activation of intracellular signals leading to specific cellular responses.  
 
Epidermal growth factor (EGF) consists of two families of structurally related ligands: the 
EGF-like growth factors and the neuregulins. The former family includes transforming 
growth-factor alpha (TGFα), heparin-binding EGF (HB-EGF), betacellulin (BTC) and 
epiregulin (ERP) and amphiregulin (AR) (Lee et al., 2003; Troyer and Lee, 2001). EGF family 
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members transmit their growth-modulating signals by binding to and activating receptors with 
intrinsic tyrosine kinase activity (Plowman et al., 1990).  
 
Tyrosine kinase receptors (TRK) belong to the ERBB family that are essential for the normal 
development and are prominent targets for dysregulation in cancer (Lee et al., 2003). The 
ERBB-signalling network comprises four homologous receptor tyrosine kinase named ERBB1 
– 4 after the prototype EGF receptor (EGFR)/ERBB1 (Troyer and Lee, 2001). The binding of 
the polypeptide ligand results in receptor homo or heterodimerization with activation of the 
intrinsic tyrosine kinase, leading to the transphosphorylation of ERBB cytoplasmic tails 
(Troyer and Lee, 2001). The phosphorylated tyrosines then serve as docking sites for 
cytoplasmic signaling proteins, resulting in the activation of various downstream pathways, 
including Ras-MAP kinase cascade, phosphatidylinositol-3 kinase and Stat transcription 
factors (Troyer and Lee, 2001). The overall downstream signaling events may be involved in 
regulation of cell proliferation, migration, differentiation or survival depending on cell type 
and context.  
 
AR protein was first discovered in MCF-7 cells and was termed amphiregulin to reflect it 
bifunctional activities: it inhibits the growth of many human tumor cells and stimulate 
proliferation of normal fibroblasts (Shoyab et al., 1988; 1989). This protein is a heparin-
binding glycoprotein and exists as monomer as of either 78 or 84 amino acids long. AR 
primarily composed of basic, hydrophilic residues as with other growth factors (Plowman et 
al., 1990). AR mRNA had been found in ovary, testis, breast, placenta, pancreas, heart, colon, 
lungs and brain (Plowman et al., 1990; Falk et al., 2002).  
 
Recently, AR has been demonstrated as a potent EGF in adult neural stem cell (Falk et al. 
2002). Its mRNA is highly expressed in choroid plexus as well as in hippocampal cells thus 
suggesting that AR may regulate neural stem cell proliferation and neurogenesis in the adult 
brain (Falk et al., 2002). It is also highly expressed in vascular smooth muscle cells (Kato et 
al., 2003). This mitogen can also upregulate its own mRNA as well as α-thrombin. In addition, 




















Figure 5.2: The ERBB signaling network. The four ERBB receptors are shown along with 
their activating EGF family and tyrosine kinase activity. Amphiregulin and ERBB1/ EGFR are 
required for ductal morphogenesis, but is unclear whether ERBB2 is involved in this process. 





As mentioned earlier, neural stem cell cultures could be initiated with AR as the only growth 
factor, demonstrating that at last some neural stem cells are responsive to AR in vivo. Fraction 
RP6.3F4  BmKII upregulated the expression of AR gene 4-fold in vitro. This could mean that 
AR could be used as a potential therapy to replace lost neurons in neurological diseases, either 
by expanding the stem cells in vitro to transplant cells or by stimulating the neurogenesis in 






5.3.3 GABA (A) receptor α-5 subunit  
 
Although the brain is undoubtedly the most complex organ, it is possible to distil the way it 
works into two opposing forces; excitation and inhibition. Neurons using neurotransmitters 
receptor system, are excited by neurotransmitter glutamate and inhibited by the 
neurotransmitter γ-aminobutyric acid (GABA; Whiting, 1999). GABA (A) receptors are 
ligand-gated ion channels that are the major modulators of the inhibitory tone throughout the 
central nervous system (CNS). They are the site of action of a number of clinically important 
drugs, including benzodiazepines (BZs), barbiturates, and anesthetics (Whiting, 2001). It is 
generally accepted that this receptor is a pentamer with an integral protein chloride ion channel 
formed by the second transmembrane domain of each of the five subunits (Sur et al., 1998).  
 
Over- or under-activity of excitatory or inhibitory force has been proposed to play a role in a 
variety of neurodegenerative conditions such as stroke, Parkinson’s disease, epilepsy, 
schizophrenia and anxiety (Kemp and McKernan, 2002; Meldrum and Whiting, 2001). In the 
late 1980s and 1990s, with the application of molecular biology approaches, it becomes clear 
that GABA (A) receptor subtypes are formed by co-assembly from 16 subunits (α 1 – 6, β1 – 
3, γ1 – 3, δ, ε, π, θ; Whiting, 2001). Information of the physiological role of the various 
subunits was contributed by gene knock-out studies (Collinson et al., 2002).  
 
The primary role of the GABA (A) receptors α5 subunit had remained undefined until gene 
knock-out studies were performed. α5-containing receptors have a particularly restricted 
distribution in the hippocampus (Sur et al., 1998, 1999), cortex and olfactory bulb (Rosahl et 
al., 2003). This localization suggests the receptor subtype may have a role to play in learning 
and memory (Collinson et al., 2002).  
 
Mice lacking α5-subunit have been found to have no major abnormalities, have normal 
lifespan and no spontaneous seizures (Collinson et al., 2002). However, these mice 
demonstrated an improved performance in working memory task (Collinson et al., 2002).  In 
addition, another group which studied partial knock-out α5 mouse found that trace fear 
conditioning was enhanced in these mutant mice (Crestani et al., 2002). Altogether, this data 
suggest that the α-5 subunit of GABA (A) receptor has an important role in controlling 
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learning and memory, which makes the α5-containing GABA (A) receptor an interesting novel 
drug target for the development of cognition enhancers (Rosahl, 2003).  
 
In our screening experiments, BmKII crude venom upregulate GABA (A) receptor α5 subunit  
gene expression in both microarray and real time experiment. Fractions RP5.2G1, RP6.4F7, 
RP6.3F4, RP6.3F5 and RP6.2F4 at 50 ng/ml were found to upregulate the receptor gene. 
Fraction RP6.3F4 was found to upregulate the gene expression by 11.2-fold (Table 4.7).  At 
low concentration of 10ng/ml, the receptor gene expression was downregulated in all the five 
fractions. It is interesting to note that GABA (A) receptor is a chloride channel. However, the 
major toxin in these five fractions were found to be alpha-toxins which bind to sodium 
channels. Therefore, we can actually perform binding activity of toxin-receptor in vitro. 
  
5.3.4 Sensory and motor-neuron derived factor (neuregulin) 
 
Neuregulins belong to the family of ERBB ligands. The neuregulins include numerous 
isoforms derived from four independent genes by alternative splicing. One of the neuregulin 
isoforms, a sensory and motor-neuron derived factor (SMDF) directly binds ERBB3 and 
ERBB4. It has been suggested that mammalian differentiation is regulated by neuregulin 
receptors (Troyer and Lee, 2001). SMDF is a neural-specific gene and is found expressed in 
human brain, spinal cord, and dorsal root ganglia (Ho et al., 1995). The high expression level 
of mRNA is maintained in the adult rat motor neurons and dorsal root ganglia. SMDF is 
biologically active and upon ligand – receptor interaction stimulates tyrosine phosphorylation 
of a 185kD protein (Hayes et al., 1992).  
 
The biological functions of SMDF are varied. Its high expression in spinal motor neurons and 
dorsal root ganglia in the developing human and rodents might suggests a role at the 
developing neuromuscular junction and possible role in the motor and sensory neuron 
development (Ho et al., 1995). Consistent with this, SMDF promotes Schwann cell 
proliferation as there is high level of gene expression in large neurons. Similar to other 
neuronal peptides, SMDF may be produced in the motor neuron cell body but is transported 
through the motor axons to the nerve terminal, where it exerts its effects on muscle 
acetylcholine receptor synthesis and/ or the proliferation of Schwann cells (Hall and Sanes, 
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1993). In addition, the expression of SMDF in the adult rat spinal cord motor neurons suggests 
that it may also act at mature neuromuscular junctions via reinnervation of muscle fibers by 
motor neurons following nerve damage.  
 
In our screening experiment on the BmKII fraction, we found that fractions RP5.2G1, 
RP6.4F7 and RP6.3F4 were able to increase gene expression of SMDF. These fractions can be 
tested on PC12 cells to see whether it may promote nerve growth following nerve growth 
damage in vitro. 
 
5.3.5 Fibroblast growth factor 2 (FGF2) 
 
FGF-2 is a member of a large family of structurally related proteins that affect the growth, 
differentiation, migration and survival of a wide variety of cell types (Bikfalvi et al, 1997). 
FGF2 or also known as basic FGF is a major growth factor extracted from prostatic tissue 
(Dow et al., 2000).  This molecule belongs to a member of a large family of proteins that bind 
heparin and heparin sulfate and modulate the function of a wide range of cell types.  
 
FGF-2 interacts with specific cell surface receptor proteins derived from four separate genes. 
FGF-2 has been proposed to have two separate receptor binding sites which may allow a single 
FGF-2 to bind to two receptors or to interact with a single receptor in two separate positions 
(Kan et al., 1993). FGF-2 is released from cells as result of cell damage, death and non-lethal 
membrane disruptions and they are stored in the extracellular matrix and basement membrane 
(Conrad, 1998; Folkman et al., 1988).  
 
Extracellular FGF-2 binds to cell surface receptors and heparin sulfate proteoglycans (HSPG) 
and is subjected to internalization and lysosomal degradation (Nugent and Iozzo, 2000). FGF-
2 plays major roles in development, remodeling and disease states in almost every organ 
system (Bikfalvi et al, 1997). The most well studied function of FGF-2 is its ability to regulate 
growth and function of vascular cells such as endothelial and smooth muscle cells. It has also 
been implicated in the development and growth of new blood vessels (angiogenesis) and in the 
pathogenesis of vascular diseases such as atherosclerosis (Bikfalvi et al, 1997). In addition, 
FGF-2 stimulates wound healing, tissue repair, and hematopoiesis, and stem cell survival 
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(Dow et al., 2000). FGF-2 also found to play a key role in tumorigenesis though its ability to 
induce angiogenesis.  
 
In the brain especially in cerebral cortex, hippocampus, cerebellum, retina, ciliary ganglion 
and spinal cord, FGF-2 promotes proper function of the nervous system (Dow et al., 2000). 
The authors postulated that basic FGF-2 stimulates glial cells to produce a trophic factor(s) 
which in turn elicits enhanced neuronal survival and neurite outgrowth. FGF-2 has pronounced 
effects on central nervous system astrocytes stimulating their proliferation and inducing the 
synthesis of glial fibrillary acidic protein (GFAP; Morrison et al., 1986). The summary of 
FGF2 intracellular signaling pathway is depicted in Figure 5.3. 
 
FGF-2 gene expression was increased upon treatment with RP5.2G1, RP6.4F7 and RP6.3F4.    
Since FGF2 is able to promote neurite outgrowth, these three fractions can be tested on PC12 
cells as an assay for neurite outgrowth. In addition, the synthesis of GFAP can be measured by 

































Figure 5.3: Schematic diagram of FGF-2 signalling pathways which has been shown to 
activate a number of intracellular signalling routes. Binding of FGF-2 to its receptors is 
enhanced by cell surface HSPG and leads to activation of autophosphorylation of the FGF-R 
in several tyrosine residues. Some of the phosphotyrosine residues are binding sites for src 
homology domain containing proteins such as phospholipase C-  and others are binding sites 
for proteins with phosphotyrosine-binding domains such as FGF receptor substrate 2 (FRS2) 
and SHC. SHC and FRS2 function as docking proteins which bind the GRB2–SOS complex 
which then activates RAS. RAS recruits RAF-1, a serine/threonine kinase that actives MEK. 
MEK proceeds to activate the mitogen activated protein kinases (MAPK) which translocate to 
the nucleus where they directly activate transcription factors by phosphorylation. The 
activation of PLC-  also plays a major role in transmitting the eventual FGF-2-mediated 
biological signals. PLC-  activation results in hydrolysis of phosphatidylinositol to inositol-3-
phosphate and diacylglycerol (DAG) leading to Ca2+ release and activation of protein kinase C 
(PKC). The biological end responses for FGF-2 may lead to stimulation of cell proliferation 










Krit1 (for Krev Interaction Trapped 1) is a protein of 529 amino acid, with a amino-terminal 
ankyrin repeat domain and a novel carboxyl-terminal domain required for association with 
Krev-1 (Serebriiskii et al., 1997). Krev-1 is an evolutionarily conserved Ras-family GTPase 
whose cellular function remains unclear but has been proposed to function as a tumor 
suprressor gene and may act as a Ras antagonist. Mutation of krit1 caused cerebral cavernous 
malformations (CCM), a type of congenital vascular anomalies of the brain that can cause 
significant neurological disabilities, including intractable seizures and hemorrhagic stroke 
(Sahoo et al., 1999). Interaction of Krev-1 and Krit1 may involve in signaling pathway in 
angiogenesis and cerebovascular disease.  
 
So far, not much is known about Krit1 as it is not strongly homologous to any previously 
described protein. Krit1 is suspected to interact weakly with a family of cytoskeletal and 
membrane-associated proteins defined by erythrocyte protein 4.1 (Conboy et al., 1986). It may 
also be a potential positive regulator of Krev-1 activity and provide an indirect mechanism to 
enhance tumor progression (Serebriiskii et al., 1997). As additional evidence for Krit1 
involvement in tumor suppression processes, krit1 ortholog was found to be transcriptionally 
upregulated in Chinese hamster ovary (CHO) cell.  In addition, Krit1 may act in localizing the 
Krev-1 to an appropriate cellular compartment for function in tumor progression and cellular 
growth control (Serebriiskii et al., 1997).  
 
Northern analysis of krit1 showed weak expression in heart, muscle and brain but not in a 
number of other tissues (Serebriiskii et al., 1997).  In the screening experiment, several 
fractions of BmKII were found to alter Krit1 gene expression. BmKII downregulated the gene 
expression of Krit1 by 5-fold and 22-fold in microarray and real-time studies respectively. 
Intriguingly, subfractions of RP1–9 upregulated Krit1 gene expression. Fraction RP5.2 caused 







5.4 Conclusion and future studies 
 
A proteomics study can be performed by checking the protein profile of the six genes using 
Western Blot. Each of the fractions RP5.2G1, RP6.2F4, RP6.3F4, RP6.3F5 and RP6.4F7 can 
be individually tested on the neuroblastoma cell line to check for presence of amphiregulin, 
neuregulin, Krit1, GABA (A) receptor, FGF2 and galanin protein expression level using 
specific antibody. This may provide useful evidence whether these toxin fractions caused any 
translational regulation as it did at the transcriptional level.  
 
So far, the role of these toxins focused largely on the physiological function at the Na+ 
channel. RP5.2G1 which shares sequence similarity to bukatoxin and BmK T toxins (Table 
4.9). Bukatoxin belongs to α-toxins family that prolongs the action potential of excitable cells 
by blocking sodium channel inactivation and neuronal transmission. It can also produce a 
marked, concentration-dependent relaxation of precontracted rat anococcygeus muscle (ACM; 
Srinivasan et al., 2001). BmK T has anti tumor effect and strong inhibitory effect on pain (Liu 
et al., 2003). BmK toxin I, a voltage-gated Na+ channel modulator was found to evoke 
profound change in c-Fos protein expression pattern in rat spinal cord (Bai et al., 2003). The 
authors found that BmK toxin I may be a key contributor of c-Fos expression induced by BmK 
venom. It is noteworthy that we also found certain protein fractions in BmKII venom was able 
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